MTOR
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00141 | S422 | SIGNOR|EPSD|PSP | SGK1 SGK | PDsVLVTAsVKEAAEAFLGFsYAPPTDSFL___________ |
| O00418 | S70 | SIGNOR | EEF2K | QNVNSKVNKYysNLtKsERysssGsPANsFHFKEAWKHAIQ |
| O00418 | S72 | SIGNOR|EPSD|PSP | EEF2K | VNSKVNKYysNLtKsERysssGsPANsFHFKEAWKHAIQKA |
| O00418 | S74 | SIGNOR|EPSD|PSP | EEF2K | SKVNKYysNLtKsERysssGsPANsFHFKEAWKHAIQKAKH |
| O00418 | Y69 | SIGNOR | EEF2K | NQNVNSKVNKYysNLtKsERysssGsPANsFHFKEAWKHAI |
| O00429 | S616 | SIGNOR | DNM1L DLP1 DRP1 | SKAEELLAEEKsKPIPIMPAsPQKGHAVNLLDVPVPVARKL |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O60260 | S127 | SIGNOR|PSP | PRKN PARK2 | LsssVLPGDSVGLAVILHTDsRKDsPPAGsPAGRSIyNSFY |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75179 | S2045 | EPSD|PSP | ANKRD17 GTAR KIAA0697 | TNATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLDCGs |
| O75179 | S2047 | EPSD|PSP | ANKRD17 GTAR KIAA0697 | ATYPMPTAKEHyPVssPssPsPPAQPGGVsRNsPLDCGsAs |
| O75385 | S638 | EPSD|PSP | ULK1 KIAA0722 | PPILGsPtKAVPSFDFPKtPssQNLLALLARQGVVMTPPRN |
| O75385 | S758 | SIGNOR|EPSD|PSP | ULK1 KIAA0722 | HPGARAGGtSSPSPVVFtVGsPPsGstPPQGPRTRMFsAGP |
| O95163 | S1174 | SIGNOR|PSP | ELP1 IKAP IKBKAP | DDEVPHGQESDLFsEtssVVsGSEMSGKYSHSNSRISARSS |
| O95747 | S339 | EPSD|PSP | OXSR1 KIAA1101 OSR1 | RRVPGssGRLHKtEDGGWEWsDDEFDEEsEEGKAAIsQLRs |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| O95817 | S289 | EPSD|PSP | BAG3 BIS | sVQGAssREGsPARsstPLHsPsPIRVHtVVDRPQQPMTHR |
| O95817 | T285 | EPSD|PSP | BAG3 BIS | PFRssVQGAssREGsPARsstPLHsPsPIRVHtVVDRPQQP |
| O96018 | S7 | EPSD|PSP | APBA3 MINT3 X11L2 | ______________MDFPtIsRsPsGPPAMDLEGPRDILVP |
| O96018 | T5 | EPSD|PSP | APBA3 MINT3 X11L2 | ________________MDFPtIsRsPsGPPAMDLEGPRDIL |
| P00441 | T40 | EPSD|PSP | SOD1 | NFEQKEsNGPVKVWGSIKGLtEGLHGFHVHEFGDNtAGCts |
| P01106 | S77 | PSP | MYC BHLHE39 | PPAPSEDIWKKFELLPtPPLsPsRRsGLCsPSyVAVTPFsL |
| P03372 | S104 | EPSD|PSP | ESR1 ESR NR3A1 | SEAAAFGSNGLGGFPPLNsVsPsPLMLLHPPPQLsPFLQPH |
| P03372 | S106 | EPSD|PSP | ESR1 ESR NR3A1 | AAAFGSNGLGGFPPLNsVsPsPLMLLHPPPQLsPFLQPHGQ |
| P03372 | S118 | PSP | ESR1 ESR NR3A1 | PPLNsVsPsPLMLLHPPPQLsPFLQPHGQQVPYYLENEPSG |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04198 | S62 | EPSD|PSP | MYCN BHLHE37 NMYC | STPPGEDIWKKFELLPtPPLsPsRGFAEHSSEPPSWVTEML |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S452 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AFSKNLKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEy |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P10275 | S96 | PSP | AR DHTR NR3C4 | QQQQQETsPRQQQQQQGEDGsPQAHRRGPTGYLVLDEEQQP |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17987 | S544 | Sugiyama | TCP1 CCT1 CCTA | ILRIDDLIKLHPESKDDKHGsyEDAVHsGALND________ |
| P19484 | S122 | EPSD|PSP | TFEB BHLHE35 | NKFAAHIsPAQGsPKPPPAAsPGVRAGHVLSssAGNsAPNs |
| P19484 | S142 | SIGNOR | TFEB BHLHE35 | sPGVRAGHVLSssAGNsAPNsPMAMLHIGsNPERELDDVID |
| P19484 | S211 | SIGNOR|EPSD|PSP | TFEB BHLHE35 | LNVYSSDPQVTASLVGVTSSsCPADLTQKRELTDAESRALA |
| P23443 | S394 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RPS6KB1 STK14A | QsEEDVsQFDSKFtRQtPVDsPDDstLsEsANQVFLGFtYV |
| P23443 | S434 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RPS6KB1 STK14A | VAPSVLESVKEKFsFEPKIRsPRRFIGsPRtPVsPVKFsPG |
| P23443 | S447 | GPS6|ELM|iPTMNet|EPSD | RPS6KB1 STK14A | sFEPKIRsPRRFIGsPRtPVsPVKFsPGDFWGRGASASTAN |
| P23443 | T390 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | RPS6KB1 STK14A | KPLLQsEEDVsQFDSKFtRQtPVDsPDDstLsEsANQVFLG |
| P23443 | T412 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RPS6KB1 STK14A | VDsPDDstLsEsANQVFLGFtYVAPSVLESVKEKFsFEPKI |
| P23443 | T444 | EPSD | RPS6KB1 STK14A | EKFsFEPKIRsPRRFIGsPRtPVsPVKFsPGDFWGRGASAS |
| P23921 | S631 | SIGNOR|PSP | RRM1 RR1 | LGNNESIEPYTSNIYTRRVLsGEFQIVNPHLLKDLTERGLW |
| P26358 | S714 | EPSD|PSP | DNMT1 AIM CXXC9 DNMT | MAMKEADDDEEVDDNIPEMPsPKKMHQGKKKKQNKNRIsWV |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27708 | S1038 | Sugiyama | CAD | QLPNNMAMALHRQQCRVLGtsPEAIDSAENRFKFSRLLDTI |
| P27797 | S195 | Sugiyama | CALR CRTC | IVRPDNtyEVKIDNsQVEsGsLEDDWDFLPPKKIKDPDAsK |
| P29966 | S26 | Sugiyama | MARCKS MACS PRKCSL | SKTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAs |
| P31749 | S473 | GPS6|SIGNOR|EPSD|PSP | AKT1 PKB RAC | DQDDSMECVDSERRPHFPQFsysAsGtA_____________ |
| P31749 | S477 | SIGNOR | AKT1 PKB RAC | SMECVDSERRPHFPQFsysAsGtA_________________ |
| P31749 | T450 | SIGNOR|EPSD|PSP | AKT1 PKB RAC | TSETDTRYFDEEFtAQMItItPPDQDDSMECVDSERRPHFP |
| P31749 | T479 | SIGNOR | AKT1 PKB RAC | ECVDSERRPHFPQFsysAsGtA___________________ |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35568 | S307 | SIGNOR | IRS1 | HHLNNPPPSQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVR |
| P35568 | S312 | SIGNOR | IRS1 | PPPSQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVRAssDG |
| P35568 | S315 | SIGNOR | IRS1 | SQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVRAssDGEGt |
| P35568 | S616 | SIGNOR | IRS1 | GGHHRPDsstLHtDDGyMPMsPGVAPVPSGRKGsGDyMPMs |
| P35568 | S636 | SIGNOR|PSP | IRS1 | sPGVAPVPSGRKGsGDyMPMsPKsVSAPQQIINPIRRHPQR |
| P35568 | S639 | SIGNOR|PSP | IRS1 | VAPVPSGRKGsGDyMPMsPKsVSAPQQIINPIRRHPQRVDP |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40763 | S727 | SIGNOR | STAT3 APRF | KTKFICVtPttCsNtIDLPMsPRTLDSLMQFGNNGEGAEPS |
| P42345 | S2159 | EPSD | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | AVPGTYDPNQPIIRIQSIAPsLQVItSKQRPRKLTLMGSNG |
| P42345 | S2448 | PSP | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | NWRLMDTNTKGNKRsRtRtDsYsAGQsVEILDGVELGEPAH |
| P42345 | S2454 | EPSD|PSP | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | TNTKGNKRsRtRtDsYsAGQsVEILDGVELGEPAHKKtGtt |
| P42345 | S2478 | EPSD|PSP | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | LDGVELGEPAHKKtGttVPEsIHsFIGDGLVKPEALNKKAI |
| P42345 | S2481 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | VELGEPAHKKtGttVPEsIHsFIGDGLVKPEALNKKAIQII |
| P42345 | T2446 | EPSD | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | LLNWRLMDTNTKGNKRsRtRtDsYsAGQsVEILDGVELGEP |
| P42345 | T2473 | EPSD|PSP | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | QsVEILDGVELGEPAHKKtGttVPEsIHsFIGDGLVKPEAL |
| P42345 | T2474 | EPSD|PSP | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | sVEILDGVELGEPAHKKtGttVPEsIHsFIGDGLVKPEALN |
| P46937 | S436 | SIGNOR|PSP | YAP1 YAP65 | FLNsVDEMDTGDTINQSTLPsQQNRFPDyLEAIPGTNVDLG |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P51397 | S3 | GPS6|SIGNOR|EPSD | DAP DAP1 | __________________MssPPEGKLETKAGHPPAVKAGG |
| P51397 | S51 | GPS6|SIGNOR|EPSD|PSP | DAP DAP1 | PHTGDTKEEKDKDDQEWEsPsPPKPtVFISGVIARGDKDFP |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55199 | S309 | EPSD|PSP | ELL C19orf17 | VRKLCQPQSTGSLLGDPAAssPPGERGRsAsPPQKRLQPPD |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62753 | S235 | PSP | RPS6 OK/SW-cl.2 | KRMKEAKEKRQEQIAKRRRLssLRAstsKsEssQK______ |
| P62753 | S236 | PSP | RPS6 OK/SW-cl.2 | RMKEAKEKRQEQIAKRRRLssLRAstsKsEssQK_______ |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| Q00613 | S303 | PSP | HSF1 HSTF1 | SIDERPLSSsPLVRVKEEPPsPPQsPRVEEAsPGRPssVDt |
| Q00613 | S326 | EPSD|PSP | HSF1 HSTF1 | QsPRVEEAsPGRPssVDtLLsPtALIDsILREsEPAPAsVT |
| Q02156 | S729 | PSP | PRKCE PKCE | LtLVDEAIVKQINQEEFKGFsYFGEDLMP____________ |
| Q02156 | T566 | PSP | PRKCE PKCE | CKLADFGMCKEGILNGVTTTtFCGTPDyIAPEILQELEYGP |
| Q02156 | T710 | SIGNOR|PSP | PRKCE PKCE | KTKRDVNNFDQDFtREEPVLtLVDEAIVKQINQEEFKGFsY |
| Q07820 | S64 | PSP | MCL1 BCL2L3 | ARREIGGGEAGAVIGGSAGAsPPstLtPDSRRVARPPPIGA |
| Q09161 | T21 | Sugiyama | NCBP1 CBP80 NCBP | MSRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEK |
| Q13322 | S150 | GPS6|EPSD | GRB10 GRBIR KIAA0207 | FRtssLPAIPNPFPELCGPGsPPVLtPGSLPPSQAAAKQDV |
| Q13322 | S428 | EPSD|PSP | GRB10 GRBIR KIAA0207 | RIPQQRKALLsPFstPVRsVsENsLVAMDFSGQTGRVIENP |
| Q13322 | S476 | GPS6|EPSD|PSP | GRB10 GRBIR KIAA0207 | LEEGHAWRKRSTRMNILGsQsPLHPstLSTVIHRTQHWFHG |
| Q13322 | T155 | EPSD|PSP | GRB10 GRBIR KIAA0207 | LPAIPNPFPELCGPGsPPVLtPGSLPPSQAAAKQDVKVFSE |
| Q13541 | S101 | GPS6|ELM|iPTMNet|EPSD | EIF4EBP1 | VtsPssDEPPMEAsQsHLRNsPEDKRAGGEEsQFEMDI___ |
| Q13541 | S44 | EPSD|PSP | EIF4EBP1 | GDGVQLPPGDysttPGGtLFsttPGGtRIIyDRKFLMECRN |
| Q13541 | S65 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | EIF4EBP1 | ttPGGtRIIyDRKFLMECRNsPVtKtPPRDLPtIPGVtsPs |
| Q13541 | S83 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | EIF4EBP1 | RNsPVtKtPPRDLPtIPGVtsPssDEPPMEAsQsHLRNsPE |
| Q13541 | T36 | GPS6|SIGNOR | EIF4EBP1 | PATRRVVLGDGVQLPPGDysttPGGtLFsttPGGtRIIyDR |
| Q13541 | T37 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | EIF4EBP1 | ATRRVVLGDGVQLPPGDysttPGGtLFsttPGGtRIIyDRK |
| Q13541 | T41 | EPSD|PSP | EIF4EBP1 | VVLGDGVQLPPGDysttPGGtLFsttPGGtRIIyDRKFLME |
| Q13541 | T45 | GPS6|SIGNOR | EIF4EBP1 | DGVQLPPGDysttPGGtLFsttPGGtRIIyDRKFLMECRNs |
| Q13541 | T46 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | EIF4EBP1 | GVQLPPGDysttPGGtLFsttPGGtRIIyDRKFLMECRNsP |
| Q13541 | T70 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | EIF4EBP1 | tRIIyDRKFLMECRNsPVtKtPPRDLPtIPGVtsPssDEPP |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q15652 | T505 | SIGNOR | JMJD1C JHDM2C KIAA1380 TRIP8 | MDKTHTMELLPKEKFVSRPPtPKCVIDItNDtNLEKVAQEN |
| Q16513 | T958 | PSP | PKN2 PRK2 PRKCL2 | RGREDVSNFDDEFtsEAPILtPPREPRILsEEEQEMFRDFD |
| Q5T4S7 | S2932 | EPSD|PSP | UBR4 KIAA0462 KIAA1307 RBAF600 | sGRSSAYGDATAEGHPAGPGsVSSSTGAISTTTGHQEGDGS |
| Q5VT52 | S1180 | Sugiyama | RPRD2 KIAA0460 HSPC099 | TGFKTAPYKERAPQFQEsVGsFRsNsFNstFEHHLPPsPLE |
| Q641Q2 | S700 | EPSD|PSP | WASHC2A FAM21A FAM21B | SQKKTQRVsLLFEDDVDsGGsLFGsPPtsVPPATKKKETVS |
| Q641Q2 | S704 | EPSD|PSP | WASHC2A FAM21A FAM21B | TQRVsLLFEDDVDsGGsLFGsPPtsVPPATKKKETVSEAPP |
| Q6GYQ0 | S860 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | DEFIAERLRSGNASTMTRRGssPGsLEIPKDLPDILNKQNQ |
| Q6PKG0 | S766 | EPSD|PSP | LARP1 KIAA0731 LARP | PtDALANKLFGAPEPstIARsLPttVPEsPNyRNtRtPRtP |
| Q6PKG0 | S774 | EPSD|PSP | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6ZN18 | S206 | Sugiyama | AEBP2 | DEGYGTGGGGSSATSGGRRGsLEMssDGEPLSRMDSEDSIS |
| Q86TB9 | S179 | EPSD|PSP | PATL1 OK/KNS-cl.5 | PQGPEDDRDLSERALPRRstsPIIGsPPVRAVPIGtPPKQM |
| Q86TB9 | S184 | EPSD|PSP | PATL1 OK/KNS-cl.5 | DDRDLSERALPRRstsPIIGsPPVRAVPIGtPPKQMAVPSF |
| Q8IYB3 | T572 | EPSD|PSP | SRRM1 SRM160 | PPPTRRRRsPsPAPPPRRRRtPtPPPRRRtPsPPPRRRSPS |
| Q8IYB3 | T574 | EPSD|PSP | SRRM1 SRM160 | PTRRRRsPsPAPPPRRRRtPtPPPRRRtPsPPPRRRSPSPR |
| Q8N122 | S855 | SIGNOR | RPTOR KIAA1303 RAPTOR | NSIAYKATVNARPQRVLDtssLtQsAPAsPtNKGVHIHQAG |
| Q8N122 | S859 | SIGNOR|EPSD|PSP | RPTOR KIAA1303 RAPTOR | YKATVNARPQRVLDtssLtQsAPAsPtNKGVHIHQAGGsPP |
| Q8N122 | S863 | SIGNOR|EPSD|PSP | RPTOR KIAA1303 RAPTOR | VNARPQRVLDtssLtQsAPAsPtNKGVHIHQAGGsPPAsst |
| Q8N1F8 | S404 | PSP | STK11IP KIAA1898 LIP1 LKB1IP STK11IP1 | RRASISEPSDTDPEPRTLNPsPAGWFVQQHPELELMSSFRE |
| Q8N201 | S495 | Sugiyama | INTS1 KIAA1440 UNQ1821/PRO3434 | KFLAMVFQDLLTNKDDYLRAsRALLREIIKQTKHEINFQAF |
| Q8N3D4 | S1257 | Sugiyama | EHBP1L1 | EGLVNGAGAPGGGGVRLRRPsVNGEPGSVPPPRAHGsFsHV |
| Q8N3Y1 | S85 | SIGNOR | FBXW8 FBW6 FBW8 FBX29 FBXO29 FBXW6 | RPPAARATRAEGQDVASRSRsPLAREGAGGGEQLVDQLIRD |
| Q8NHG8 | S145 | EPSD|PSP | ZNRF2 RNF202 | GGGRDRPVGGsPGGPRLVIGsLPAHLsPHMFGGFKCPVCSK |
| Q8TB45 | S265 | EPSD|PSP | DEPTOR DEPDC6 | PFCLRKQSHDNRKstsFMsVsPsKEIKIVSAVRRssMssCG |
| Q8TB45 | S286 | EPSD|PSP | DEPTOR DEPDC6 | PsKEIKIVSAVRRssMssCGssGyFsssPtLsssPPVLCNP |
| Q8TB45 | S293 | SIGNOR|EPSD|PSP | DEPTOR DEPDC6 | VSAVRRssMssCGssGyFsssPtLsssPPVLCNPKSVLKRP |
| Q8TB45 | S299 | SIGNOR|EPSD|PSP | DEPTOR DEPDC6 | ssMssCGssGyFsssPtLsssPPVLCNPKSVLKRPVtsEEL |
| Q8TB45 | T295 | EPSD|PSP | DEPTOR DEPDC6 | AVRRssMssCGssGyFsssPtLsssPPVLCNPKSVLKRPVt |
| Q8TBX8 | S324 | SIGNOR|PSP | PIP4K2C PIP5K2C | EDESEVDGDCSLTGPPALVGsYGTsPEGIGGYIHSHRPLGP |
| Q8TBX8 | S328 | SIGNOR|PSP | PIP4K2C PIP5K2C | EVDGDCSLTGPPALVGsYGTsPEGIGGYIHSHRPLGPGEFE |
| Q96B36 | S183 | GPS6|SIGNOR|EPSD|PSP | AKT1S1 PRAS40 | GPPTCSVPPASALPTQQYAKsLPVSVPVWGFKEKRtEARss |
| Q96B36 | S212 | GPS6|SIGNOR | AKT1S1 PRAS40 | GFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAED |
| Q96B36 | S221 | SIGNOR|EPSD|PSP | AKT1S1 PRAS40 | RssDEENGPPssPDLDRIAAsMRALVLREAEDtQVFGDLPR |
| Q96F24 | S113 | SIGNOR|PSP | NRBF2 COPR | DAAAHLQTSHKPsAEDAEGQsPLsQKysPstEKCLPEIQGI |
| Q96F24 | S120 | SIGNOR|PSP | NRBF2 COPR | TSHKPsAEDAEGQsPLsQKysPstEKCLPEIQGIFDRDPDT |
| Q96KG9 | S754 | PSP | SCYL1 CVAK90 GKLP NTKL TAPK TEIF TRAP HT019 | DKGDPFAtLsARPstQPRPDsWGEDNWEGLETDSRQVKAEL |
| Q96RG2 | S949 | PSP | PASK KIAA0135 | VKDLLHsQRDsAARTRLFLAsLPGstHstAAELTGPSLVEV |
| Q96RG2 | S953 | PSP | PASK KIAA0135 | LHsQRDsAARTRLFLAsLPGstHstAAELTGPSLVEVLRAR |
| Q96RG2 | S956 | PSP | PASK KIAA0135 | QRDsAARTRLFLAsLPGstHstAAELTGPSLVEVLRARPWF |
| Q96RG2 | T640 | PSP | PASK KIAA0135 | WWRSQDLAPSPSGMAGLSFGtPtLDEPWLGVENDREELQTC |
| Q96RG2 | T642 | PSP | PASK KIAA0135 | RSQDLAPSPSGMAGLSFGtPtLDEPWLGVENDREELQTCLI |
| Q99497 | S57 | Sugiyama | PARK7 | GLAGKDPVQCsRDVVICPDAsLEDAKKEGPyDVVVLPGGNL |
| Q9BPZ7 | S260 | EPSD|PSP | MAPKAP1 MIP1 SIN1 | EVDTDFPPLDSNEPIHKFGFsTLALVEKYSsPGLTSKESLF |
| Q9BRS8 | S348 | SIGNOR|EPSD|PSP | LARP6 | QYMGDESSANSSSDPEsNPtsPMAGRRHAATNKLSPSGHQN |
| Q9BRS8 | S409 | SIGNOR|EPSD|PSP | LARP6 | RKGVSRKsPLAEEGRLNCstsPEIFRKCMDYSsDSSVTPSG |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C7 | S52 | SIGNOR|EPSD|PSP | AMBRA1 DCAF3 KIAA1736 | LVEDKTRWMKWEGKRVELPDsPRSTFLLAFSPDRTLLASTH |
| Q9H063 | S60 | GPS6|SIGNOR|EPSD|PSP | MAF1 | DKHMFKQFCQEGQPHVLEALsPPQtsGLsPsRLsKsQGGEE |
| Q9H063 | S68 | GPS6|SIGNOR|EPSD|PSP | MAF1 | CQEGQPHVLEALsPPQtsGLsPsRLsKsQGGEEEGPLSDKC |
| Q9H063 | S75 | GPS6|SIGNOR|EPSD|PSP | MAF1 | VLEALsPPQtsGLsPsRLsKsQGGEEEGPLSDKCSRKTLFY |
| Q9H1K1 | S14 | SIGNOR|EPSD|PSP | ISCU NIFUN | _______MAAAGAFRLRRAAsALLLRsPRLPARELsAPARL |
| Q9H4A3 | S2032 | EPSD|PSP | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | sDPEAAFLSRDVDDGsGsPHsPHQLssKSLPSQNLSQSLSN |
| Q9H4L4 | S139 | PSP | SENP3 SSP3 SUSP3 | RKTCSQRRRRAMRAFRMLLYsKstsLtFHWKLWGRHRGRRR |
| Q9H4L4 | S141 | PSP | SENP3 SSP3 SUSP3 | TCSQRRRRAMRAFRMLLYsKstsLtFHWKLWGRHRGRRRGL |
| Q9H4L4 | S143 | PSP | SENP3 SSP3 SUSP3 | SQRRRRAMRAFRMLLYsKstsLtFHWKLWGRHRGRRRGLAH |
| Q9H4L4 | S25 | PSP | SENP3 SSP3 SUSP3 | IQGTGSWGPEPPGPGIPPAyssPRRERLRWPPPPKPRLKsG |
| Q9H4L4 | S26 | PSP | SENP3 SSP3 SUSP3 | QGTGSWGPEPPGPGIPPAyssPRRERLRWPPPPKPRLKsGG |
| Q9H4L4 | T142 | PSP | SENP3 SSP3 SUSP3 | CSQRRRRAMRAFRMLLYsKstsLtFHWKLWGRHRGRRRGLA |
| Q9H4L4 | T145 | PSP | SENP3 SSP3 SUSP3 | RRRRAMRAFRMLLYsKstsLtFHWKLWGRHRGRRRGLAHPK |
| Q9H5H4 | S139 | EPSD|PSP | ZNF768 | PRyEPQsPGYEPRsPGYEPRsPGYEsEssRYESQNTELKTQ |
| Q9H714 | S157 | PSP | RUBCNL C13orf18 KIAA0226L | VRPGYSHRVSLPTSPGILATsPYPETDSAFFEPSHLTSAAD |
| Q9H8M2 | S588 | EPSD|PSP | BRD9 UNQ3040/PRO9856 | sRLsVGEQPDVtHDPYEFLQsPEPAASAKT___________ |
| Q9HB90 | S21 | PSP | RRAGC | MsLQyGAEEtPLAGsyGAADsFPKDFGYGVEEEEEEAAAAG |
| Q9HB90 | T394 | PSP | RRAGC | HRsCGHQtsAssLKALTHNGtPRNAI_______________ |
| Q9HBH9 | S74 | SIGNOR|PSP | MKNK2 GPRK7 MNK2 | IDIPDAKKRGKKKKRGRAtDsFsGRFEDVYQLQEDVLGEGA |
| Q9NQG5 | S166 | EPSD|PSP | RPRD1B C20orf77 CREPT | LKRTFQQIQEEEDDDyPGsysPQDPsAGPLLTEELIKALQD |
| Q9P2Y5 | S493 | PSP | UVRAG | SAIPVPKRQssIFGGADVGFsGGIPsPDKGHRKRAssENER |
| Q9P2Y5 | S498 | PSP | UVRAG | PKRQssIFGGADVGFsGGIPsPDKGHRKRAssENERLQyKt |
| Q9P2Y5 | S508 | PSP | UVRAG | ADVGFsGGIPsPDKGHRKRAssENERLQyKtPPPsyNsALA |
| Q9P2Y5 | S522 | PSP | UVRAG | GHRKRAssENERLQyKtPPPsyNsALAQPVTTVPSMGETER |
| Q9P2Y5 | S549 | PSP | UVRAG | QPVTTVPSMGETERKITSLSssLDtsLDFSKENKKKGEDLV |
| Q9P2Y5 | S550 | SIGNOR|EPSD|PSP | UVRAG | PVTTVPSMGETERKITSLSssLDtsLDFSKENKKKGEDLVG |
| Q9P2Y5 | S571 | SIGNOR|EPSD|PSP | UVRAG | LDtsLDFSKENKKKGEDLVGsLNGGHANVHPsQEQGEALSG |
| Q9P2Y5 | S582 | PSP | UVRAG | KKKGEDLVGsLNGGHANVHPsQEQGEALSGHRATVNGTLLP |
| Q9UBS0 | S370 | SIGNOR|EPSD | RPS6KB2 STK14B | QSEEDVSQFDTRFTRQTPVDsPDDTALSESANQAFLGFtYV |
| Q9UBS0 | T228 | SIGNOR|EPSD | RPS6KB2 STK14B | IKLTDFGLCKESIHEGAVTHtFCGTIEYMAPEILVRSGHNR |
| Q9UBS0 | T388 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | RPS6KB2 STK14B | VDsPDDTALSESANQAFLGFtYVAPSVLDSIKEGFsFQPKL |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9UPY5 | S26 | SIGNOR|PSP | SLC7A11 | VVStISKGGyLQGNVNGRLPsLGNKEPPGQEKVQLKRKVTL |
| Q9UQ35 | S1318 | EPSD|PSP | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | VPsMASSWGGPHFsPEHKELsNsPLRENsFGsPLEFRNsGP |
| Q9UQ35 | S1326 | EPSD|PSP | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | GGPHFsPEHKELsNsPLRENsFGsPLEFRNsGPLGTEMNtG |
| Q9UQ35 | S1329 | EPSD|PSP | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | HFsPEHKELsNsPLRENsFGsPLEFRNsGPLGTEMNtGFss |
| Q9Y2J4 | S759 | SIGNOR|EPSD|PSP | AMOTL2 KIAA0989 | TCLPPEPDSLLGCSSSQRAAsLDsVATSRVQDLSDMVEILI |
| Q9Y6W6 | S224 | EPSD|PSP | DUSP10 MKP5 | RLQQGKITVLDLISCREGKDsFKRIFsKEIIVYDENTNEPS |
| Q9Y6W6 | S230 | EPSD|PSP | DUSP10 MKP5 | ITVLDLISCREGKDsFKRIFsKEIIVYDENTNEPSRVMPSQ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Regulation of TP53 Activity | R-HSA-5633007 | 0.000001 | 5.866 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 0.000017 | 4.762 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 0.000023 | 4.648 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 0.000026 | 4.592 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 0.000048 | 4.318 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 0.000055 | 4.263 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 0.000065 | 4.184 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 0.000074 | 4.130 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 0.000094 | 4.025 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 0.000140 | 3.853 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 0.000232 | 3.635 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 0.000256 | 3.592 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 0.000566 | 3.247 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 0.000549 | 3.260 | 1 | 0 |
| Cell junction organization | R-HSA-446728 | 0.000510 | 3.293 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 0.000534 | 3.272 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 0.000649 | 3.188 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 0.000712 | 3.148 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 0.000717 | 3.145 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 0.000820 | 3.086 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 0.000820 | 3.086 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 0.000867 | 3.062 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 0.000902 | 3.045 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 0.000980 | 3.009 | 1 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 0.001577 | 2.802 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 0.001577 | 2.802 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 0.001803 | 2.744 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 0.002183 | 2.661 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 0.002463 | 2.608 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 0.002716 | 2.566 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 0.002873 | 2.542 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 0.003011 | 2.521 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 0.003167 | 2.499 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 0.003551 | 2.450 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 0.004010 | 2.397 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 0.004054 | 2.392 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 0.003907 | 2.408 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 0.004087 | 2.389 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 0.004341 | 2.362 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 0.004734 | 2.325 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 0.004696 | 2.328 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 0.004696 | 2.328 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 0.005042 | 2.297 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 0.005474 | 2.262 | 1 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 0.006317 | 2.200 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 0.006317 | 2.200 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 0.005874 | 2.231 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 0.006116 | 2.214 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 0.005924 | 2.227 | 1 | 1 |
| Cell-cell junction organization | R-HSA-421270 | 0.006317 | 2.200 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 0.006122 | 2.213 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 0.006799 | 2.168 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 0.006911 | 2.160 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 0.007332 | 2.135 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 0.007743 | 2.111 | 1 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 0.009008 | 2.045 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 0.009106 | 2.041 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 0.009106 | 2.041 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 0.009202 | 2.036 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 0.008620 | 2.065 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 0.008620 | 2.065 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 0.008889 | 2.051 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 0.009643 | 2.016 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 0.009643 | 2.016 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 0.009566 | 2.019 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 0.011311 | 1.946 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 0.011311 | 1.946 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 0.011061 | 1.956 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 0.011061 | 1.956 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 0.011914 | 1.924 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 0.011496 | 1.939 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 0.013560 | 1.868 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 0.012983 | 1.887 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 0.013081 | 1.883 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 0.014814 | 1.829 | 1 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 0.015927 | 1.798 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 0.015141 | 1.820 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 0.015927 | 1.798 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 0.018523 | 1.732 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 0.017801 | 1.750 | 0 | 0 |
| M Phase | R-HSA-68886 | 0.018504 | 1.733 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 0.017694 | 1.752 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 0.018592 | 1.731 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 0.018592 | 1.731 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 0.018743 | 1.727 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 0.019764 | 1.704 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 0.022424 | 1.649 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 0.022424 | 1.649 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 0.022424 | 1.649 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 0.022424 | 1.649 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 0.022424 | 1.649 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 0.022424 | 1.649 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 0.022424 | 1.649 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 0.022424 | 1.649 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 0.020328 | 1.692 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 0.021500 | 1.668 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 0.021651 | 1.665 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 0.024387 | 1.613 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 0.023912 | 1.621 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 0.024866 | 1.604 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 0.025428 | 1.595 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 0.025971 | 1.586 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 0.025971 | 1.586 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 0.026617 | 1.575 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 0.027458 | 1.561 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 0.028189 | 1.550 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 0.028189 | 1.550 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 0.028361 | 1.547 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 0.028912 | 1.539 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 0.029142 | 1.535 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 0.032338 | 1.490 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 0.031645 | 1.500 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 0.032338 | 1.490 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 0.031562 | 1.501 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 0.033687 | 1.473 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 0.034013 | 1.468 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 0.034543 | 1.462 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 0.038796 | 1.411 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 0.038796 | 1.411 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 0.037967 | 1.421 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 0.037759 | 1.423 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 0.038066 | 1.419 | 1 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 0.038796 | 1.411 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 0.039344 | 1.405 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 0.041420 | 1.383 | 1 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 0.041736 | 1.379 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 0.041736 | 1.379 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 0.041736 | 1.379 | 1 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 0.042743 | 1.369 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 0.042842 | 1.368 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 0.046941 | 1.328 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 0.044856 | 1.348 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 0.046845 | 1.329 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 0.044666 | 1.350 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 0.047301 | 1.325 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 0.047432 | 1.324 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 0.047432 | 1.324 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 0.047432 | 1.324 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 0.050380 | 1.298 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 0.050380 | 1.298 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 0.050380 | 1.298 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 0.051593 | 1.287 | 1 | 1 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 0.052735 | 1.278 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 0.054039 | 1.267 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 0.049608 | 1.304 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 0.050766 | 1.294 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 0.052565 | 1.279 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 0.052565 | 1.279 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 0.055376 | 1.257 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 0.055376 | 1.257 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 0.057792 | 1.238 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 0.057829 | 1.238 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 0.057829 | 1.238 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 0.057829 | 1.238 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 0.065073 | 1.187 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 0.065073 | 1.187 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 0.065073 | 1.187 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 0.058619 | 1.232 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 0.058619 | 1.232 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 0.058619 | 1.232 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 0.062246 | 1.206 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 0.063653 | 1.196 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 0.065073 | 1.187 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 0.065484 | 1.184 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 0.065484 | 1.184 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 0.065484 | 1.184 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 0.107926 | 0.967 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 0.107926 | 0.967 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 0.077382 | 1.111 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 0.077382 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 0.077382 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 0.077382 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 0.077382 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 0.077382 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 0.077382 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 0.077382 | 1.111 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 0.077382 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 0.077382 | 1.111 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 0.077382 | 1.111 | 0 | 0 |
| MGMT-mediated DNA damage reversal | R-HSA-5657655 | 0.204209 | 0.690 | 0 | 0 |
| Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) | R-HSA-9036092 | 0.204209 | 0.690 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 0.204209 | 0.690 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 0.204209 | 0.690 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 0.112430 | 0.949 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 0.150662 | 0.822 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 0.150662 | 0.822 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 0.150662 | 0.822 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 0.150662 | 0.822 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 0.150662 | 0.822 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 0.150662 | 0.822 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 0.150662 | 0.822 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 0.150662 | 0.822 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 0.290105 | 0.537 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 0.290105 | 0.537 | 0 | 0 |
| Defective GALE causes EDG | R-HSA-5609977 | 0.290105 | 0.537 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 0.290105 | 0.537 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 0.290105 | 0.537 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 0.290105 | 0.537 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 0.290105 | 0.537 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 0.290105 | 0.537 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 0.290105 | 0.537 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 0.290105 | 0.537 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 0.290105 | 0.537 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 0.290105 | 0.537 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 0.108134 | 0.966 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 0.108134 | 0.966 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 0.108134 | 0.966 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 0.190982 | 0.719 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 0.190982 | 0.719 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 0.190982 | 0.719 | 0 | 0 |
| IRS activation | R-HSA-74713 | 0.190982 | 0.719 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 0.190982 | 0.719 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 0.190982 | 0.719 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 0.132871 | 0.877 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 0.132871 | 0.877 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 0.132871 | 0.877 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 0.095058 | 1.022 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 0.113029 | 0.947 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 0.113029 | 0.947 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 0.113029 | 0.947 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 0.113029 | 0.947 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 0.113029 | 0.947 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 0.113029 | 0.947 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 0.113029 | 0.947 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 0.113029 | 0.947 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 0.159346 | 0.798 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 0.159346 | 0.798 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 0.232497 | 0.634 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 0.232497 | 0.634 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 0.232497 | 0.634 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 0.232497 | 0.634 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 0.232497 | 0.634 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 0.232497 | 0.634 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 0.366735 | 0.436 | 0 | 0 |
| MPS IIIC - Sanfilippo syndrome C | R-HSA-2206291 | 0.366735 | 0.436 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 0.366735 | 0.436 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 0.366735 | 0.436 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 0.366735 | 0.436 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 0.366735 | 0.436 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 0.366735 | 0.436 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 0.366735 | 0.436 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 0.095518 | 1.020 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 0.132369 | 0.878 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 0.187253 | 0.728 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 0.187253 | 0.728 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 0.110355 | 0.957 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 0.110355 | 0.957 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 0.092394 | 1.034 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 0.152956 | 0.815 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 0.152956 | 0.815 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 0.274477 | 0.561 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 0.274477 | 0.561 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 0.077655 | 1.110 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 0.126232 | 0.899 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 0.126232 | 0.899 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 0.126232 | 0.899 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 0.216295 | 0.665 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 0.087778 | 1.057 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 0.174655 | 0.758 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 0.174655 | 0.758 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 0.143089 | 0.844 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 0.082590 | 1.083 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 0.082590 | 1.083 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 0.110143 | 0.958 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 0.246186 | 0.609 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 0.246186 | 0.609 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 0.246186 | 0.609 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 0.316341 | 0.500 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 0.316341 | 0.500 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 0.316341 | 0.500 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 0.316341 | 0.500 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 0.435096 | 0.361 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 0.435096 | 0.361 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 0.435096 | 0.361 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 0.435096 | 0.361 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 0.435096 | 0.361 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 0.435096 | 0.361 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 0.435096 | 0.361 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 0.435096 | 0.361 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 0.435096 | 0.361 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 0.072045 | 1.142 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 0.122356 | 0.912 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 0.122356 | 0.912 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 0.179460 | 0.746 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 0.179460 | 0.746 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 0.220829 | 0.656 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 0.220829 | 0.656 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 0.220829 | 0.656 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 0.220829 | 0.656 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 0.087258 | 1.059 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 0.276660 | 0.558 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 0.113636 | 0.944 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 0.179655 | 0.746 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 0.357624 | 0.447 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 0.357624 | 0.447 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 0.357624 | 0.447 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 0.218847 | 0.660 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 0.307469 | 0.512 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 0.307469 | 0.512 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 0.269751 | 0.569 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 0.239462 | 0.621 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 0.075976 | 1.119 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 0.154443 | 0.811 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 0.260574 | 0.584 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 0.260574 | 0.584 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 0.294892 | 0.530 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 0.338389 | 0.471 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 0.338389 | 0.471 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 0.397964 | 0.400 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 0.496082 | 0.304 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 0.496082 | 0.304 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 0.496082 | 0.304 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 0.496082 | 0.304 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 0.165720 | 0.781 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 0.224670 | 0.648 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 0.282096 | 0.550 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 0.282096 | 0.550 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 0.320309 | 0.494 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 0.320309 | 0.494 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 0.320309 | 0.494 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 0.320309 | 0.494 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 0.320309 | 0.494 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 0.166544 | 0.778 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 0.269825 | 0.569 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 0.369216 | 0.433 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 0.369216 | 0.433 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 0.369216 | 0.433 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 0.303942 | 0.517 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 0.345876 | 0.461 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 0.345876 | 0.461 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 0.437083 | 0.359 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 0.437083 | 0.359 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 0.437083 | 0.359 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 0.326028 | 0.487 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 0.399773 | 0.398 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 0.399773 | 0.398 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 0.399773 | 0.398 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 0.240860 | 0.618 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 0.240860 | 0.618 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 0.293141 | 0.533 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 0.371476 | 0.430 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 0.254456 | 0.594 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 0.348271 | 0.458 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 0.328415 | 0.484 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 0.328415 | 0.484 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 0.296418 | 0.528 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 0.370592 | 0.431 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 0.396999 | 0.401 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 0.429902 | 0.367 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 0.474776 | 0.324 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 0.474776 | 0.324 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 0.474776 | 0.324 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 0.474776 | 0.324 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 0.474776 | 0.324 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 0.474776 | 0.324 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 0.550487 | 0.259 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 0.550487 | 0.259 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 0.550487 | 0.259 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 0.550487 | 0.259 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 0.550487 | 0.259 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 0.550487 | 0.259 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 0.550487 | 0.259 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 0.227394 | 0.643 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 0.368353 | 0.434 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 0.392917 | 0.406 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 0.422344 | 0.374 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 0.422344 | 0.374 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 0.362231 | 0.441 | 1 | 1 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 0.321754 | 0.492 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 0.379225 | 0.421 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 0.447420 | 0.349 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 0.510894 | 0.292 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 0.510894 | 0.292 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 0.510894 | 0.292 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 0.396261 | 0.402 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 0.488353 | 0.311 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 0.488353 | 0.311 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 0.488353 | 0.311 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 0.420534 | 0.376 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 0.448339 | 0.348 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 0.480903 | 0.318 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 0.516464 | 0.287 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 0.516464 | 0.287 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 0.545339 | 0.263 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 0.545339 | 0.263 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 0.545339 | 0.263 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 0.545339 | 0.263 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 0.545339 | 0.263 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 0.545339 | 0.263 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 0.545339 | 0.263 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 0.545339 | 0.263 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 0.545339 | 0.263 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 0.545339 | 0.263 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 0.599021 | 0.223 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 0.599021 | 0.223 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 0.599021 | 0.223 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 0.599021 | 0.223 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 0.599021 | 0.223 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 0.520248 | 0.284 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 0.520248 | 0.284 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 0.520248 | 0.284 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 0.543508 | 0.265 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 0.543508 | 0.265 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 0.543508 | 0.265 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 0.543508 | 0.265 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 0.578050 | 0.238 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 0.578050 | 0.238 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 0.578050 | 0.238 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 0.578050 | 0.238 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 0.578050 | 0.238 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 0.570065 | 0.244 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 0.570065 | 0.244 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 0.545536 | 0.263 | 1 | 1 |
| Signaling by Erythropoietin | R-HSA-9006335 | 0.566172 | 0.247 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 0.566172 | 0.247 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 0.566172 | 0.247 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 0.588199 | 0.230 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 0.595445 | 0.225 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 0.595445 | 0.225 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 0.595445 | 0.225 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 0.595445 | 0.225 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 0.116052 | 0.935 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 0.166544 | 0.778 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 0.087987 | 1.056 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 0.296418 | 0.528 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 0.224670 | 0.648 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 0.162851 | 0.788 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 0.122356 | 0.912 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 0.250883 | 0.601 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 0.152058 | 0.818 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 0.303942 | 0.517 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 0.389041 | 0.410 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 0.532525 | 0.274 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 0.532525 | 0.274 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 0.206387 | 0.685 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 0.094432 | 1.025 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 0.156976 | 0.804 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 0.532525 | 0.274 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 0.188133 | 0.726 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 0.392917 | 0.406 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 0.516464 | 0.287 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 0.578022 | 0.238 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 0.187253 | 0.728 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 0.069462 | 1.158 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 0.214243 | 0.669 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 0.530429 | 0.275 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 0.328509 | 0.483 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 0.566172 | 0.247 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 0.113029 | 0.947 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 0.187253 | 0.728 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 0.348271 | 0.458 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 0.247647 | 0.606 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 0.577022 | 0.239 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 0.077655 | 1.110 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 0.263093 | 0.580 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 0.611658 | 0.213 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 0.576503 | 0.239 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 0.104964 | 0.979 | 1 | 1 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 0.221486 | 0.655 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 0.468067 | 0.330 | 1 | 1 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 0.316341 | 0.500 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 0.122356 | 0.912 | 1 | 1 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 0.095539 | 1.020 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 0.095539 | 1.020 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 0.095539 | 1.020 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 0.113636 | 0.944 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 0.074466 | 1.128 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 0.117828 | 0.929 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 0.497636 | 0.303 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 0.156456 | 0.806 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 0.068250 | 1.166 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 0.383807 | 0.416 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 0.218482 | 0.661 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 0.216295 | 0.665 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 0.082590 | 1.083 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 0.123931 | 0.907 | 1 | 1 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 0.093173 | 1.031 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 0.397964 | 0.400 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 0.209246 | 0.679 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 0.396261 | 0.402 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 0.487600 | 0.312 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 0.563736 | 0.249 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 0.276660 | 0.558 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 0.121462 | 0.916 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 0.497931 | 0.303 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 0.358839 | 0.445 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 0.077382 | 1.111 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 0.078569 | 1.105 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 0.190982 | 0.719 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 0.068166 | 1.166 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 0.068582 | 1.164 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 0.437083 | 0.359 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 0.184979 | 0.733 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 0.310018 | 0.509 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 0.447420 | 0.349 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 0.338219 | 0.471 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 0.603073 | 0.220 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 0.141427 | 0.849 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 0.130551 | 0.884 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 0.269751 | 0.569 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 0.232336 | 0.634 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 0.119183 | 0.924 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 0.370592 | 0.431 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 0.392917 | 0.406 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 0.523293 | 0.281 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 0.113029 | 0.947 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 0.082590 | 1.083 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 0.192762 | 0.715 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 0.397964 | 0.400 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 0.399773 | 0.398 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 0.598691 | 0.223 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 0.369392 | 0.433 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 0.374724 | 0.426 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 0.374724 | 0.426 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 0.374724 | 0.426 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 0.374724 | 0.426 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 0.325369 | 0.488 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 0.576579 | 0.239 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 0.132871 | 0.877 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 0.132369 | 0.878 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 0.246186 | 0.609 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 0.357624 | 0.447 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 0.307469 | 0.512 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 0.397964 | 0.400 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 0.496082 | 0.304 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 0.138595 | 0.858 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 0.369216 | 0.433 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 0.275202 | 0.560 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 0.516464 | 0.287 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 0.545339 | 0.263 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 0.520248 | 0.284 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 0.423555 | 0.373 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 0.523293 | 0.281 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 0.494370 | 0.306 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 0.357831 | 0.446 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 0.113636 | 0.944 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 0.437299 | 0.359 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 0.260574 | 0.584 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 0.162851 | 0.788 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 0.303942 | 0.517 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 0.235860 | 0.627 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 0.186634 | 0.729 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 0.069864 | 1.156 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 0.198655 | 0.702 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 0.394567 | 0.404 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 0.545339 | 0.263 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 0.578050 | 0.238 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 0.078718 | 1.104 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 0.308604 | 0.511 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 0.119425 | 0.923 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 0.068166 | 1.166 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 0.392917 | 0.406 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 0.092042 | 1.036 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 0.358839 | 0.445 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 0.366051 | 0.436 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 0.192805 | 0.715 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 0.307469 | 0.512 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 0.177538 | 0.751 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 0.371476 | 0.430 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 0.427848 | 0.369 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 0.251571 | 0.599 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 0.543917 | 0.264 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 0.112380 | 0.949 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 0.328997 | 0.483 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 0.357840 | 0.446 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 0.190982 | 0.719 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 0.190982 | 0.719 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 0.187253 | 0.728 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 0.069462 | 1.158 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 0.316341 | 0.500 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 0.095539 | 1.020 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 0.123988 | 0.907 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 0.496082 | 0.304 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 0.496082 | 0.304 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 0.289101 | 0.539 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 0.437083 | 0.359 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 0.550487 | 0.259 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 0.550487 | 0.259 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 0.459466 | 0.338 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 0.480903 | 0.318 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 0.608843 | 0.215 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 0.258451 | 0.588 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 0.335691 | 0.474 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 0.171403 | 0.766 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 0.383807 | 0.416 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 0.383807 | 0.416 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 0.480903 | 0.318 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 0.374724 | 0.426 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 0.108710 | 0.964 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 0.289101 | 0.539 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 0.516464 | 0.287 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 0.589114 | 0.230 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 0.474776 | 0.324 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 0.496441 | 0.304 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 0.113029 | 0.947 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 0.307469 | 0.512 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 0.369216 | 0.433 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 0.437388 | 0.359 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 0.225401 | 0.647 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 0.148394 | 0.829 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 0.282380 | 0.549 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 0.340504 | 0.468 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 0.423208 | 0.373 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 0.212675 | 0.672 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 0.514381 | 0.289 | 1 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 0.152956 | 0.815 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 0.435096 | 0.361 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 0.338389 | 0.471 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 0.397964 | 0.400 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 0.496082 | 0.304 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 0.496082 | 0.304 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 0.303942 | 0.517 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 0.459466 | 0.338 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 0.510894 | 0.292 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 0.314801 | 0.502 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 0.599021 | 0.223 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 0.599021 | 0.223 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 0.570065 | 0.244 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 0.488353 | 0.311 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 0.404167 | 0.393 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 0.525921 | 0.279 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 0.098612 | 1.006 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 0.160857 | 0.794 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 0.396999 | 0.401 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 0.355373 | 0.449 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 0.543722 | 0.265 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 0.578050 | 0.238 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 0.228116 | 0.642 | 1 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 0.175061 | 0.757 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 0.147566 | 0.831 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 0.545339 | 0.263 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 0.202860 | 0.693 | 1 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 0.274477 | 0.561 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 0.357624 | 0.447 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 0.294892 | 0.530 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 0.496082 | 0.304 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 0.369216 | 0.433 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 0.303942 | 0.517 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 0.468067 | 0.330 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 0.393061 | 0.406 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 0.369216 | 0.433 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 0.563028 | 0.249 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 0.159346 | 0.798 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 0.459466 | 0.338 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 0.516464 | 0.287 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 0.523197 | 0.281 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 0.564110 | 0.249 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 0.237306 | 0.625 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 0.480258 | 0.319 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 0.069161 | 1.160 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 0.595607 | 0.225 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 0.174434 | 0.758 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 0.195820 | 0.708 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 0.257602 | 0.589 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 0.545339 | 0.263 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 0.488353 | 0.311 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 0.339153 | 0.470 | 1 | 0 |
| Ion homeostasis | R-HSA-5578775 | 0.311799 | 0.506 | 0 | 0 |
| Depurination | R-HSA-73927 | 0.583838 | 0.234 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 0.114483 | 0.941 | 1 | 0 |
| Macroautophagy | R-HSA-1632852 | 0.272021 | 0.565 | 1 | 1 |
| Programmed Cell Death | R-HSA-5357801 | 0.126079 | 0.899 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 0.204209 | 0.690 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 0.112430 | 0.949 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 0.150662 | 0.822 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 0.150662 | 0.822 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 0.290105 | 0.537 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 0.290105 | 0.537 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 0.126232 | 0.899 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 0.197327 | 0.705 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 0.246186 | 0.609 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 0.316341 | 0.500 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 0.435096 | 0.361 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 0.276660 | 0.558 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 0.135700 | 0.867 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 0.269751 | 0.569 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 0.192762 | 0.715 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 0.397964 | 0.400 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 0.496082 | 0.304 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 0.496082 | 0.304 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 0.437083 | 0.359 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 0.263093 | 0.580 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 0.308651 | 0.511 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 0.399773 | 0.398 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 0.399773 | 0.398 | 0 | 0 |
| Kinesins | R-HSA-983189 | 0.254456 | 0.594 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 0.268304 | 0.571 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 0.268304 | 0.571 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 0.370592 | 0.431 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 0.474776 | 0.324 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 0.550487 | 0.259 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 0.550487 | 0.259 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 0.510894 | 0.292 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 0.510894 | 0.292 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 0.437299 | 0.359 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 0.488353 | 0.311 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 0.472144 | 0.326 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 0.545339 | 0.263 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 0.545339 | 0.263 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 0.599021 | 0.223 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 0.599021 | 0.223 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 0.599021 | 0.223 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 0.595492 | 0.225 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 0.609558 | 0.215 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 0.103539 | 0.985 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 0.577737 | 0.238 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 0.195820 | 0.708 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 0.270194 | 0.568 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 0.337814 | 0.471 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 0.285768 | 0.544 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 0.310018 | 0.509 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 0.289101 | 0.539 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 0.399773 | 0.398 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 0.500413 | 0.301 | 1 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 0.123931 | 0.907 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 0.348335 | 0.458 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 0.338389 | 0.471 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 0.225401 | 0.647 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 0.396999 | 0.401 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 0.154740 | 0.810 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 0.468067 | 0.330 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 0.490433 | 0.309 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 0.609875 | 0.215 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 0.285017 | 0.545 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 0.437083 | 0.359 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 0.347174 | 0.459 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 0.082590 | 1.083 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 0.221486 | 0.655 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 0.416106 | 0.381 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 0.296661 | 0.528 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 0.296661 | 0.528 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 0.159346 | 0.798 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 0.437083 | 0.359 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 0.237234 | 0.625 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 0.232003 | 0.635 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 0.069161 | 1.160 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 0.246186 | 0.609 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 0.121462 | 0.916 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 0.282750 | 0.549 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 0.495021 | 0.305 | 1 | 1 |
| Base Excision Repair | R-HSA-73884 | 0.247290 | 0.607 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 0.384004 | 0.416 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 0.270361 | 0.568 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 0.232497 | 0.634 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 0.232497 | 0.634 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 0.092042 | 1.036 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 0.357624 | 0.447 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 0.162851 | 0.788 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 0.397964 | 0.400 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 0.369216 | 0.433 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 0.258246 | 0.588 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 0.254456 | 0.594 | 1 | 1 |
| Heme signaling | R-HSA-9707616 | 0.282380 | 0.549 | 0 | 0 |
| S Phase | R-HSA-69242 | 0.202940 | 0.693 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 0.437299 | 0.359 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 0.599021 | 0.223 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 0.578050 | 0.238 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 0.369216 | 0.433 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 0.408466 | 0.389 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 0.108134 | 0.966 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 0.338389 | 0.471 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 0.179655 | 0.746 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 0.135229 | 0.869 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 0.459466 | 0.338 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 0.570065 | 0.244 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 0.269751 | 0.569 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 0.563028 | 0.249 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 0.187654 | 0.727 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 0.150662 | 0.822 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 0.290105 | 0.537 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 0.232497 | 0.634 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 0.246186 | 0.609 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 0.316341 | 0.500 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 0.435096 | 0.361 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 0.435096 | 0.361 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 0.179460 | 0.746 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 0.276660 | 0.558 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 0.437083 | 0.359 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 0.371476 | 0.430 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 0.496441 | 0.304 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 0.516464 | 0.287 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 0.371476 | 0.430 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 0.562527 | 0.250 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 0.320309 | 0.494 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 0.402179 | 0.396 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 0.543917 | 0.264 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 0.437083 | 0.359 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 0.247366 | 0.607 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 0.543917 | 0.264 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 0.274477 | 0.561 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 0.435096 | 0.361 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 0.102089 | 0.991 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 0.130815 | 0.883 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 0.208486 | 0.681 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 0.397964 | 0.400 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 0.369216 | 0.433 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 0.256385 | 0.591 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 0.474776 | 0.324 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 0.406636 | 0.391 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 0.554067 | 0.256 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 0.562810 | 0.250 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 0.351887 | 0.454 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 0.307455 | 0.512 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 0.369216 | 0.433 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 0.279106 | 0.554 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 0.209937 | 0.678 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 0.231959 | 0.635 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 0.366735 | 0.436 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 0.435096 | 0.361 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 0.220829 | 0.656 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 0.174178 | 0.759 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 0.174178 | 0.759 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 0.187984 | 0.726 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 0.241271 | 0.617 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 0.437083 | 0.359 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 0.550487 | 0.259 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 0.488353 | 0.311 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 0.599021 | 0.223 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 0.506896 | 0.295 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 0.491784 | 0.308 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 0.595445 | 0.225 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 0.418950 | 0.378 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 0.506896 | 0.295 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 0.328415 | 0.484 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 0.345876 | 0.461 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 0.399773 | 0.398 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 0.516464 | 0.287 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 0.408882 | 0.388 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 0.114003 | 0.943 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 0.126232 | 0.899 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 0.570065 | 0.244 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 0.422344 | 0.374 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 0.316341 | 0.500 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 0.148012 | 0.830 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 0.397964 | 0.400 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 0.399773 | 0.398 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 0.399773 | 0.398 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 0.279106 | 0.554 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 0.480903 | 0.318 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 0.543722 | 0.265 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 0.528275 | 0.277 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 0.595445 | 0.225 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 0.606033 | 0.218 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 0.383807 | 0.416 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 0.546527 | 0.262 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 0.501187 | 0.300 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 0.160845 | 0.794 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 0.480903 | 0.318 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 0.599021 | 0.223 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 0.459466 | 0.338 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 0.595445 | 0.225 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 0.474776 | 0.324 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 0.550487 | 0.259 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 0.599021 | 0.223 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 0.545339 | 0.263 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 0.402686 | 0.395 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 0.447309 | 0.349 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 0.484463 | 0.315 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 0.429902 | 0.367 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 0.437083 | 0.359 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 0.437083 | 0.359 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 0.619826 | 0.208 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 0.619826 | 0.208 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 0.619826 | 0.208 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 0.619826 | 0.208 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 0.619826 | 0.208 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 0.619826 | 0.208 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 0.619826 | 0.208 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 0.621791 | 0.206 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 0.621791 | 0.206 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 0.621791 | 0.206 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 0.621791 | 0.206 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 0.621791 | 0.206 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 0.621791 | 0.206 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 0.621791 | 0.206 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 0.624686 | 0.204 | 1 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 0.633766 | 0.198 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 0.637740 | 0.195 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 0.638189 | 0.195 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 0.638189 | 0.195 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 0.638189 | 0.195 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 0.638189 | 0.195 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 0.639972 | 0.194 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 0.642317 | 0.192 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 0.642317 | 0.192 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 0.642317 | 0.192 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 0.642317 | 0.192 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 0.642317 | 0.192 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 0.642317 | 0.192 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 0.642317 | 0.192 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 0.642317 | 0.192 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 0.642317 | 0.192 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 0.642317 | 0.192 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 0.642317 | 0.192 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 0.642317 | 0.192 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 0.642317 | 0.192 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 0.643188 | 0.192 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 0.643188 | 0.192 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 0.643188 | 0.192 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 0.649100 | 0.188 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 0.649624 | 0.187 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 0.656148 | 0.183 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 0.657599 | 0.182 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 0.658014 | 0.182 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 0.660481 | 0.180 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 0.665516 | 0.177 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 0.665516 | 0.177 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 0.665636 | 0.177 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 0.665636 | 0.177 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 0.665636 | 0.177 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 0.665636 | 0.177 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 0.665746 | 0.177 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 0.674662 | 0.171 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 0.676116 | 0.170 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 0.680470 | 0.167 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 0.680470 | 0.167 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 0.680941 | 0.167 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 0.680941 | 0.167 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 0.680941 | 0.167 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 0.680941 | 0.167 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 0.680941 | 0.167 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 0.680941 | 0.167 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 0.680941 | 0.167 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 0.680941 | 0.167 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 0.680941 | 0.167 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 0.680941 | 0.167 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 0.680941 | 0.167 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 0.680941 | 0.167 | 0 | 0 |
| Reuptake of GABA | R-HSA-888593 | 0.680941 | 0.167 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 0.680941 | 0.167 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 0.680941 | 0.167 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 0.680941 | 0.167 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 0.680941 | 0.167 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 0.680941 | 0.167 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 0.686807 | 0.163 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 0.686807 | 0.163 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 0.686807 | 0.163 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 0.686807 | 0.163 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 0.686807 | 0.163 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 0.686807 | 0.163 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 0.687861 | 0.162 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 0.687861 | 0.162 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 0.687861 | 0.162 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 0.687861 | 0.162 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 0.689087 | 0.162 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 0.691150 | 0.160 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 0.691150 | 0.160 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 0.691376 | 0.160 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 0.691376 | 0.160 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 0.691376 | 0.160 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 0.691376 | 0.160 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 0.695454 | 0.158 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 0.695768 | 0.158 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 0.700235 | 0.155 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 0.705595 | 0.151 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 0.707058 | 0.151 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 0.707066 | 0.151 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 0.707066 | 0.151 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 0.707066 | 0.151 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 0.713621 | 0.147 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 0.713621 | 0.147 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 0.715396 | 0.145 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 0.715396 | 0.145 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 0.715396 | 0.145 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 0.715396 | 0.145 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 0.715396 | 0.145 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 0.715396 | 0.145 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 0.715396 | 0.145 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 0.715396 | 0.145 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 0.715396 | 0.145 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 0.715396 | 0.145 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 0.715396 | 0.145 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 0.715396 | 0.145 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 0.715396 | 0.145 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 0.715459 | 0.145 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 0.715459 | 0.145 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 0.715459 | 0.145 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 0.715459 | 0.145 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 0.715459 | 0.145 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 0.717692 | 0.144 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 0.721809 | 0.142 | 1 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 0.721977 | 0.141 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 0.722586 | 0.141 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 0.722586 | 0.141 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 0.723988 | 0.140 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 0.726304 | 0.139 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 0.726304 | 0.139 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 0.726304 | 0.139 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 0.726304 | 0.139 | 1 | 1 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 0.726304 | 0.139 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 0.726304 | 0.139 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 0.730114 | 0.137 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 0.733346 | 0.135 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 0.737535 | 0.132 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 0.737941 | 0.132 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 0.737941 | 0.132 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 0.738837 | 0.131 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 0.739566 | 0.131 | 1 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 0.739688 | 0.131 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 0.740957 | 0.130 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 0.744537 | 0.128 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 0.744537 | 0.128 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 0.746131 | 0.127 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 0.746131 | 0.127 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 0.746131 | 0.127 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 0.746131 | 0.127 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 0.746131 | 0.127 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 0.746131 | 0.127 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 0.746131 | 0.127 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 0.746131 | 0.127 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 0.746131 | 0.127 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 0.746131 | 0.127 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 0.746131 | 0.127 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 0.747540 | 0.126 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 0.750600 | 0.125 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 0.751287 | 0.124 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 0.752942 | 0.123 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 0.754305 | 0.122 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 0.754357 | 0.122 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 0.754357 | 0.122 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 0.755033 | 0.122 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 0.758888 | 0.120 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 0.758888 | 0.120 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 0.758888 | 0.120 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 0.758888 | 0.120 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 0.758888 | 0.120 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 0.758888 | 0.120 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 0.758888 | 0.120 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 0.760520 | 0.119 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 0.761787 | 0.118 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 0.761787 | 0.118 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 0.763076 | 0.117 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 0.763186 | 0.117 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 0.763186 | 0.117 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 0.770886 | 0.113 | 1 | 1 |
| Metabolism of RNA | R-HSA-8953854 | 0.772677 | 0.112 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 0.773550 | 0.112 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 0.773550 | 0.112 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 0.773550 | 0.112 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 0.773550 | 0.112 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 0.773550 | 0.112 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 0.773550 | 0.112 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 0.773550 | 0.112 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 0.773550 | 0.112 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 0.773550 | 0.112 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 0.773550 | 0.112 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 0.773550 | 0.112 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 0.775656 | 0.110 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 0.777157 | 0.109 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 0.777888 | 0.109 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 0.778080 | 0.109 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 0.778369 | 0.109 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 0.778369 | 0.109 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 0.778369 | 0.109 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 0.778369 | 0.109 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 0.778369 | 0.109 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 0.779392 | 0.108 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 0.783246 | 0.106 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 0.783246 | 0.106 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 0.783528 | 0.106 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 0.785352 | 0.105 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 0.785352 | 0.105 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 0.785352 | 0.105 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 0.790341 | 0.102 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 0.792018 | 0.101 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 0.793444 | 0.100 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 0.793809 | 0.100 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 0.795886 | 0.099 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 0.796456 | 0.099 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 0.798008 | 0.098 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 0.798008 | 0.098 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 0.798008 | 0.098 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 0.798008 | 0.098 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 0.798008 | 0.098 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 0.798008 | 0.098 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 0.798111 | 0.098 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 0.798111 | 0.098 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 0.798439 | 0.098 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 0.802243 | 0.096 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 0.805498 | 0.094 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 0.806023 | 0.094 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 0.806023 | 0.094 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 0.807911 | 0.093 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 0.808827 | 0.092 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 0.812977 | 0.090 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 0.813223 | 0.090 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 0.813223 | 0.090 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 0.813223 | 0.090 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 0.819826 | 0.086 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 0.819826 | 0.086 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 0.819826 | 0.086 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 0.819826 | 0.086 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 0.819826 | 0.086 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 0.819826 | 0.086 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 0.819826 | 0.086 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 0.819826 | 0.086 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 0.821427 | 0.085 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 0.821512 | 0.085 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 0.821512 | 0.085 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 0.821512 | 0.085 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 0.824436 | 0.084 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 0.828744 | 0.082 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 0.828744 | 0.082 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 0.828744 | 0.082 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 0.828746 | 0.082 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 0.831959 | 0.080 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 0.834116 | 0.079 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 0.834283 | 0.079 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 0.834753 | 0.078 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 0.838313 | 0.077 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 0.839289 | 0.076 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 0.839289 | 0.076 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 0.839289 | 0.076 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 0.839289 | 0.076 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 0.842730 | 0.074 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 0.843092 | 0.074 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 0.843092 | 0.074 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 0.843092 | 0.074 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 0.843092 | 0.074 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 0.843662 | 0.074 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 0.846259 | 0.072 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 0.846259 | 0.072 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 0.846259 | 0.072 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 0.848911 | 0.071 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 0.850857 | 0.070 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 0.850857 | 0.070 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 0.853876 | 0.069 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 0.853876 | 0.069 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 0.853876 | 0.069 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 0.855205 | 0.068 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 0.855849 | 0.068 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 0.856340 | 0.067 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 0.856650 | 0.067 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 0.856650 | 0.067 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 0.856650 | 0.067 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 0.856650 | 0.067 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 0.856650 | 0.067 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 0.857475 | 0.067 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 0.868559 | 0.061 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 0.868559 | 0.061 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 0.868559 | 0.061 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 0.868559 | 0.061 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 0.868929 | 0.061 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 0.872136 | 0.059 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 0.872136 | 0.059 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 0.872136 | 0.059 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 0.872136 | 0.059 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 0.872136 | 0.059 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 0.872136 | 0.059 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 0.872136 | 0.059 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 0.872136 | 0.059 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 0.872136 | 0.059 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 0.872136 | 0.059 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 0.872136 | 0.059 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 0.872136 | 0.059 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 0.872136 | 0.059 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 0.872136 | 0.059 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 0.872608 | 0.059 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 0.876767 | 0.057 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 0.877773 | 0.057 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 0.877773 | 0.057 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 0.877773 | 0.057 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 0.877773 | 0.057 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 0.879815 | 0.056 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 0.881172 | 0.055 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 0.885951 | 0.053 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 0.885951 | 0.053 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 0.885951 | 0.053 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 0.885951 | 0.053 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 0.885951 | 0.053 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 0.885951 | 0.053 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 0.885951 | 0.053 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 0.885951 | 0.053 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 0.885951 | 0.053 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 0.885951 | 0.053 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 0.885951 | 0.053 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 0.885951 | 0.053 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 0.885951 | 0.053 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 0.885951 | 0.053 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 0.886666 | 0.052 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 0.886925 | 0.052 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 0.889230 | 0.051 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 0.889230 | 0.051 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 0.889230 | 0.051 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 0.890173 | 0.051 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 0.890173 | 0.051 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 0.890173 | 0.051 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 0.895460 | 0.048 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 0.895460 | 0.048 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 0.896806 | 0.047 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 0.896806 | 0.047 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 0.898273 | 0.047 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 0.898273 | 0.047 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 0.898273 | 0.047 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 0.898273 | 0.047 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 0.898273 | 0.047 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 0.898273 | 0.047 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 0.898900 | 0.046 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 0.898900 | 0.046 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 0.899271 | 0.046 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 0.899698 | 0.046 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 0.899698 | 0.046 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 0.899698 | 0.046 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 0.899698 | 0.046 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 0.900193 | 0.046 | 1 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 0.902439 | 0.045 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 0.903411 | 0.044 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 0.903411 | 0.044 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 0.903411 | 0.044 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 0.905295 | 0.043 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 0.906897 | 0.042 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 0.908447 | 0.042 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 0.908447 | 0.042 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 0.908447 | 0.042 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 0.908447 | 0.042 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 0.908447 | 0.042 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 0.908447 | 0.042 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 0.908664 | 0.042 | 1 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 0.909265 | 0.041 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 0.909265 | 0.041 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 0.909265 | 0.041 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 0.909265 | 0.041 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 0.909265 | 0.041 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 0.909265 | 0.041 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 0.909265 | 0.041 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 0.909265 | 0.041 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 0.909265 | 0.041 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 0.909265 | 0.041 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 0.910601 | 0.041 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 0.910601 | 0.041 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 0.910811 | 0.041 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 0.910811 | 0.041 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 0.910827 | 0.041 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 0.911006 | 0.040 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 0.914660 | 0.039 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 0.916441 | 0.038 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 0.916477 | 0.038 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 0.916862 | 0.038 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 0.916862 | 0.038 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 0.916862 | 0.038 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 0.917693 | 0.037 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 0.917693 | 0.037 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 0.918727 | 0.037 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 0.919070 | 0.037 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 0.919070 | 0.037 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 0.919070 | 0.037 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 0.919070 | 0.037 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 0.919070 | 0.037 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 0.919070 | 0.037 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 0.919070 | 0.037 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 0.919600 | 0.036 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 0.920489 | 0.036 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 0.923842 | 0.034 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 0.923842 | 0.034 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 0.924086 | 0.034 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 0.924652 | 0.034 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 0.924914 | 0.034 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 0.925069 | 0.034 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 0.925354 | 0.034 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 0.925824 | 0.033 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 0.925824 | 0.033 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 0.926380 | 0.033 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 0.926380 | 0.033 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 0.927816 | 0.033 | 0 | 0 |
| PKA activation | R-HSA-163615 | 0.927816 | 0.033 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 0.927816 | 0.033 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 0.927816 | 0.033 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 0.927816 | 0.033 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 0.927816 | 0.033 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 0.927816 | 0.033 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 0.928221 | 0.032 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 0.928221 | 0.032 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 0.928671 | 0.032 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 0.928987 | 0.032 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 0.928987 | 0.032 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 0.928987 | 0.032 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 0.930021 | 0.032 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 0.930021 | 0.032 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 0.933358 | 0.030 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 0.933358 | 0.030 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 0.935527 | 0.029 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 0.935527 | 0.029 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 0.935617 | 0.029 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 0.935617 | 0.029 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 0.935617 | 0.029 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 0.935617 | 0.029 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 0.935617 | 0.029 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 0.935617 | 0.029 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 0.935617 | 0.029 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 0.935617 | 0.029 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 0.936571 | 0.028 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 0.936571 | 0.028 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 0.936770 | 0.028 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 0.936770 | 0.028 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 0.936770 | 0.028 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 0.936770 | 0.028 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 0.939325 | 0.027 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 0.940412 | 0.027 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 0.940466 | 0.027 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 0.940588 | 0.027 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 0.942266 | 0.026 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 0.942266 | 0.026 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 0.942575 | 0.026 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 0.942575 | 0.026 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 0.942575 | 0.026 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 0.942575 | 0.026 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 0.942575 | 0.026 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 0.942645 | 0.026 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 0.943219 | 0.025 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 0.943324 | 0.025 | 0 | 0 |
| Protein folding | R-HSA-391251 | 0.944941 | 0.025 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 0.944941 | 0.025 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 0.945356 | 0.024 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 0.945356 | 0.024 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 0.945356 | 0.024 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 0.945356 | 0.024 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 0.945356 | 0.024 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 0.945937 | 0.024 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 0.946052 | 0.024 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 0.946184 | 0.024 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 0.946184 | 0.024 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 0.947015 | 0.024 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 0.947598 | 0.023 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 0.947598 | 0.023 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 0.947598 | 0.023 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 0.948292 | 0.023 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 0.948782 | 0.023 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 0.948782 | 0.023 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 0.948782 | 0.023 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 0.948782 | 0.023 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 0.948782 | 0.023 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 0.948782 | 0.023 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 0.948782 | 0.023 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 0.948782 | 0.023 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 0.948782 | 0.023 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 0.948782 | 0.023 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 0.949731 | 0.022 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 0.949731 | 0.022 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 0.950188 | 0.022 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 0.950188 | 0.022 | 1 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 0.950735 | 0.022 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 0.950735 | 0.022 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 0.951987 | 0.021 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 0.952703 | 0.021 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 0.953777 | 0.021 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 0.953777 | 0.021 | 1 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 0.954318 | 0.020 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 0.954318 | 0.020 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 0.954374 | 0.020 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 0.956400 | 0.019 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 0.956643 | 0.019 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 0.956643 | 0.019 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 0.956643 | 0.019 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 0.957518 | 0.019 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 0.957764 | 0.019 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 0.957764 | 0.019 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 0.957764 | 0.019 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 0.959256 | 0.018 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 0.959256 | 0.018 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 0.959256 | 0.018 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 0.959256 | 0.018 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 0.959256 | 0.018 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 0.959256 | 0.018 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 0.959567 | 0.018 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 0.960584 | 0.017 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 0.960584 | 0.017 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 0.960920 | 0.017 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 0.963343 | 0.016 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 0.963343 | 0.016 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 0.963353 | 0.016 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 0.963458 | 0.016 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 0.963661 | 0.016 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 0.963661 | 0.016 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 0.963661 | 0.016 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 0.963661 | 0.016 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 0.963661 | 0.016 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 0.963661 | 0.016 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 0.964051 | 0.016 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 0.964162 | 0.016 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 0.964181 | 0.016 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 0.964181 | 0.016 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 0.965563 | 0.015 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 0.966586 | 0.015 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 0.966596 | 0.015 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 0.966596 | 0.015 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 0.967070 | 0.015 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 0.967104 | 0.015 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 0.967104 | 0.015 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 0.967245 | 0.014 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 0.967461 | 0.014 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 0.967461 | 0.014 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 0.967461 | 0.014 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 0.967589 | 0.014 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 0.967589 | 0.014 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 0.967589 | 0.014 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 0.967589 | 0.014 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 0.970450 | 0.013 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 0.970450 | 0.013 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 0.970450 | 0.013 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 0.971093 | 0.013 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 0.971093 | 0.013 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 0.971093 | 0.013 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 0.971386 | 0.013 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 0.971478 | 0.013 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 0.972172 | 0.012 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 0.972172 | 0.012 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 0.972319 | 0.012 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 0.973174 | 0.012 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 0.973194 | 0.012 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 0.973278 | 0.012 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 0.973404 | 0.012 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 0.973833 | 0.012 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 0.974219 | 0.011 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 0.974219 | 0.011 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 0.974219 | 0.011 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 0.974219 | 0.011 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 0.974219 | 0.011 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 0.975655 | 0.011 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 0.975655 | 0.011 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 0.975655 | 0.011 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 0.976511 | 0.010 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 0.976735 | 0.010 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 0.976742 | 0.010 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 0.977006 | 0.010 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 0.977006 | 0.010 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 0.977006 | 0.010 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 0.977006 | 0.010 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 0.977006 | 0.010 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 0.977006 | 0.010 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 0.977575 | 0.010 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 0.977624 | 0.010 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 0.977912 | 0.010 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 0.977912 | 0.010 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 0.977968 | 0.010 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 0.977989 | 0.010 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 0.978338 | 0.010 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 0.978693 | 0.009 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 0.978976 | 0.009 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 0.979319 | 0.009 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 0.979319 | 0.009 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 0.979319 | 0.009 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 0.979319 | 0.009 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 0.979493 | 0.009 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 0.979493 | 0.009 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 0.979493 | 0.009 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 0.979967 | 0.009 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 0.980637 | 0.008 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 0.980786 | 0.008 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 0.980934 | 0.008 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 0.981241 | 0.008 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 0.981253 | 0.008 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 0.981711 | 0.008 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 0.981717 | 0.008 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 0.981966 | 0.008 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 0.982138 | 0.008 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 0.982553 | 0.008 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 0.982775 | 0.008 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 0.983266 | 0.007 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 0.983266 | 0.007 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 0.983534 | 0.007 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 0.983534 | 0.007 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 0.983534 | 0.007 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 0.983689 | 0.007 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 0.983689 | 0.007 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 0.984074 | 0.007 | 1 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 0.984734 | 0.007 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 0.984923 | 0.007 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 0.984923 | 0.007 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 0.985045 | 0.007 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 0.985078 | 0.007 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 0.985078 | 0.007 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 0.985078 | 0.007 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 0.985093 | 0.007 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 0.985446 | 0.006 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 0.985446 | 0.006 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 0.985453 | 0.006 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 0.985453 | 0.006 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 0.985453 | 0.006 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 0.987026 | 0.006 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 0.987370 | 0.006 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 0.987919 | 0.005 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 0.988280 | 0.005 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 0.988380 | 0.005 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 0.988429 | 0.005 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 0.988429 | 0.005 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 0.988429 | 0.005 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 0.988716 | 0.005 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 0.989005 | 0.005 | 1 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 0.989681 | 0.005 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 0.989681 | 0.005 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 0.989681 | 0.005 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 0.989681 | 0.005 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 0.989681 | 0.005 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 0.990175 | 0.004 | 1 | 1 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 0.990462 | 0.004 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 0.990797 | 0.004 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 0.990797 | 0.004 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 0.990797 | 0.004 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 0.990797 | 0.004 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 0.990797 | 0.004 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 0.990914 | 0.004 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 0.990914 | 0.004 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 0.990969 | 0.004 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 0.991252 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 0.991291 | 0.004 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 0.991339 | 0.004 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 0.991437 | 0.004 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 0.991793 | 0.004 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 0.991793 | 0.004 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 0.991793 | 0.004 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 0.992309 | 0.003 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 0.992378 | 0.003 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 0.992492 | 0.003 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 0.992561 | 0.003 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 0.992681 | 0.003 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 0.992681 | 0.003 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 0.992744 | 0.003 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 0.992854 | 0.003 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 0.992854 | 0.003 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 0.992854 | 0.003 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 0.993072 | 0.003 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 0.993216 | 0.003 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 0.993271 | 0.003 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 0.993446 | 0.003 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 0.993473 | 0.003 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 0.993473 | 0.003 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 0.993473 | 0.003 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 0.993649 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 0.993961 | 0.003 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 0.994103 | 0.003 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 0.994179 | 0.003 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 0.994179 | 0.003 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 0.994179 | 0.003 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 0.994493 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 0.994809 | 0.002 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 0.994847 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 0.995156 | 0.002 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 0.995371 | 0.002 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 0.995449 | 0.002 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 0.995505 | 0.002 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 0.995805 | 0.002 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 0.995872 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 0.995872 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 0.995938 | 0.002 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 0.996083 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 0.996176 | 0.002 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 0.996319 | 0.002 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 0.996319 | 0.002 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 0.996319 | 0.002 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 0.996319 | 0.002 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 0.996330 | 0.002 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 0.996496 | 0.002 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 0.996685 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 0.996685 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 0.996717 | 0.001 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 0.997006 | 0.001 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 0.997060 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 0.997072 | 0.001 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 0.997106 | 0.001 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 0.997389 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 0.997389 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 0.997389 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 0.997389 | 0.001 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 0.997624 | 0.001 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 0.997672 | 0.001 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 0.997672 | 0.001 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 0.997672 | 0.001 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 0.997672 | 0.001 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 0.997936 | 0.001 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 0.998112 | 0.001 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 0.998144 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 0.998149 | 0.001 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 0.998337 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 0.998413 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 0.998421 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 0.998528 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 0.998675 | 0.001 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 0.998699 | 0.001 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 0.998795 | 0.001 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 0.998804 | 0.001 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 0.998829 | 0.001 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 0.998956 | 0.000 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 0.998963 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 0.998986 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 0.998992 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 0.998994 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 0.998994 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 0.999034 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 0.999085 | 0.000 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 0.999190 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 0.999260 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 0.999307 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 0.999340 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 0.999418 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 0.999431 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 0.999436 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 0.999469 | 0.000 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 0.999492 | 0.000 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 0.999495 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 0.999532 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 0.999583 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 0.999583 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 0.999614 | 0.000 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 0.999614 | 0.000 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 0.999628 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 0.999693 | 0.000 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 0.999715 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 0.999736 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 0.999736 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 0.999771 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 0.999813 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 0.999882 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 0.999893 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 0.999895 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 0.999916 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 0.999925 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 0.999925 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 0.999937 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 0.999937 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 0.999937 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 0.999946 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 0.999947 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 0.999947 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 0.999953 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 0.999958 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 0.999961 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 0.999966 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 0.999968 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 0.999969 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 0.999977 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 0.999979 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 0.999981 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 0.999981 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 0.999981 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 0.999985 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 0.999989 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 0.999990 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 0.999992 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 0.999992 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 0.999994 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 0.999994 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 0.999994 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 0.999995 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 0.999997 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 0.999997 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 0.999998 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 0.999998 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 0.999999 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 0.999999 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 0.999999 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 0.999999 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 1.000000 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000 | 0.000 | 1 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.000000 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.000000 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000 | 0.000 | 1 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000 | -0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 9.503421e-09 | 8.022 | 1 | 0 |
| Signal Transduction | R-HSA-162582 | 3.032776e-07 | 6.518 | 1 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.123646e-07 | 6.213 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.528728e-06 | 5.816 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.711174e-06 | 5.767 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.274770e-06 | 5.643 | 1 | 1 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.314713e-06 | 5.275 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.538420e-06 | 5.123 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.538420e-06 | 5.123 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.252684e-06 | 5.083 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.516848e-06 | 5.022 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.609124e-05 | 4.793 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.678376e-05 | 4.775 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.565785e-05 | 4.805 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.180056e-05 | 4.498 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.326719e-05 | 4.478 | 1 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.757694e-05 | 4.425 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.867857e-05 | 4.413 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.715361e-05 | 4.430 | 1 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.477929e-05 | 4.349 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.956524e-05 | 4.225 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.432249e-05 | 4.129 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.384007e-04 | 3.859 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.954790e-04 | 3.709 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.077811e-04 | 3.682 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.701131e-04 | 3.568 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.938643e-04 | 3.532 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.078119e-04 | 3.390 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.430765e-04 | 3.192 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.815353e-04 | 3.167 | 1 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 7.782010e-04 | 3.109 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 7.782010e-04 | 3.109 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.579237e-04 | 3.120 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.782010e-04 | 3.109 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.053179e-04 | 3.094 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 9.483464e-04 | 3.023 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.987571e-04 | 3.046 | 1 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 9.483464e-04 | 3.023 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.117856e-03 | 2.952 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.111553e-03 | 2.954 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.176641e-03 | 2.929 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.176641e-03 | 2.929 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.219384e-03 | 2.914 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.265324e-03 | 2.898 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.232540e-03 | 2.909 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.249024e-03 | 2.903 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.327813e-03 | 2.877 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.340822e-03 | 2.873 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.417105e-03 | 2.849 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.565415e-03 | 2.805 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.568423e-03 | 2.805 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.598952e-03 | 2.796 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.641864e-03 | 2.785 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.743574e-03 | 2.759 | 1 | 1 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.842820e-03 | 2.735 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.154297e-03 | 2.667 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.238124e-03 | 2.650 | 1 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.313980e-03 | 2.636 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.498264e-03 | 2.602 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.498264e-03 | 2.602 | 1 | 1 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.506303e-03 | 2.601 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.506303e-03 | 2.601 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.527797e-03 | 2.597 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.965291e-03 | 2.528 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.025486e-03 | 2.519 | 1 | 1 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.346415e-03 | 2.475 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.346415e-03 | 2.475 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.592827e-03 | 2.445 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.842114e-03 | 2.415 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.066621e-03 | 2.391 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.066621e-03 | 2.391 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.310998e-03 | 2.365 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.316555e-03 | 2.365 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.393506e-03 | 2.357 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.535199e-03 | 2.343 | 1 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.555235e-03 | 2.341 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.612624e-03 | 2.336 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.026824e-03 | 2.299 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.208042e-03 | 2.283 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.208042e-03 | 2.283 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.208042e-03 | 2.283 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.208042e-03 | 2.283 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.208042e-03 | 2.283 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.781174e-03 | 2.238 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.781174e-03 | 2.238 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.497517e-03 | 2.260 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.513371e-03 | 2.259 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 5.872856e-03 | 2.231 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.872856e-03 | 2.231 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.872856e-03 | 2.231 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.170897e-03 | 2.210 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.355851e-03 | 2.197 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.902137e-03 | 2.229 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.383688e-03 | 2.195 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.428601e-03 | 2.192 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.680364e-03 | 2.175 | 1 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 7.106875e-03 | 2.148 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.033310e-03 | 2.153 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.347993e-03 | 2.134 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.441393e-03 | 2.128 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.419900e-03 | 2.130 | 1 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.068596e-03 | 2.151 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.913874e-03 | 2.102 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.913874e-03 | 2.102 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.131861e-03 | 2.090 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 8.586055e-03 | 2.066 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.903056e-03 | 2.050 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.903056e-03 | 2.050 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.612491e-03 | 2.065 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.106019e-03 | 2.041 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.205558e-03 | 2.036 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.418649e-03 | 2.026 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 9.424144e-03 | 2.026 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.653405e-03 | 2.015 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.976178e-03 | 2.001 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.002959e-02 | 1.999 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.037232e-02 | 1.984 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.076827e-02 | 1.968 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.094248e-02 | 1.961 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.151779e-02 | 1.939 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.205009e-02 | 1.919 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.188853e-02 | 1.925 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.349646e-02 | 1.870 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.383383e-02 | 1.859 | 1 | 1 |
| Nuclear RNA decay | R-HSA-9930044 | 1.405308e-02 | 1.852 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.533979e-02 | 1.814 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.573516e-02 | 1.803 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.589987e-02 | 1.799 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.590488e-02 | 1.798 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.598619e-02 | 1.796 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.626386e-02 | 1.789 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.665344e-02 | 1.778 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.835357e-02 | 1.736 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.654955e-02 | 1.781 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.747630e-02 | 1.758 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.889186e-02 | 1.724 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.957206e-02 | 1.708 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.011543e-02 | 1.696 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.017193e-02 | 1.695 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.017193e-02 | 1.695 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.052193e-02 | 1.688 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.052193e-02 | 1.688 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.052193e-02 | 1.688 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.052193e-02 | 1.688 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.084711e-02 | 1.681 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.084711e-02 | 1.681 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.370001e-02 | 1.625 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.302388e-02 | 1.638 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.313536e-02 | 1.636 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.428955e-02 | 1.615 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.275160e-02 | 1.643 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.489938e-02 | 1.604 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.489938e-02 | 1.604 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.503447e-02 | 1.601 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.539457e-02 | 1.595 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.615510e-02 | 1.582 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.686485e-02 | 1.571 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.722756e-02 | 1.565 | 1 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.729977e-02 | 1.564 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.729977e-02 | 1.564 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.729977e-02 | 1.564 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.979839e-02 | 1.526 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.740500e-02 | 1.562 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 2.772871e-02 | 1.557 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.729977e-02 | 1.564 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.065640e-02 | 1.513 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.786907e-02 | 1.555 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.901837e-02 | 1.537 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.729977e-02 | 1.564 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.007058e-02 | 1.522 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.115563e-02 | 1.506 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.115563e-02 | 1.506 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.145873e-02 | 1.502 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.176065e-02 | 1.498 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.204882e-02 | 1.494 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.207493e-02 | 1.494 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.371688e-02 | 1.472 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.426959e-02 | 1.465 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.463380e-02 | 1.460 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.469370e-02 | 1.460 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.469370e-02 | 1.460 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.522761e-02 | 1.453 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.564542e-02 | 1.448 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.610046e-02 | 1.442 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.628554e-02 | 1.440 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.301335e-02 | 1.366 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.301335e-02 | 1.366 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.301335e-02 | 1.366 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.119186e-02 | 1.385 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.761974e-02 | 1.425 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.765031e-02 | 1.424 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.765031e-02 | 1.424 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.163341e-02 | 1.381 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.287760e-02 | 1.368 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.017969e-02 | 1.396 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.301335e-02 | 1.366 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.020377e-02 | 1.396 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.162180e-02 | 1.381 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.081890e-02 | 1.389 | 1 | 0 |
| Heme signaling | R-HSA-9707616 | 3.926741e-02 | 1.406 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.079909e-02 | 1.389 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.480522e-02 | 1.349 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.480522e-02 | 1.349 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.618267e-02 | 1.336 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.769232e-02 | 1.322 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.769232e-02 | 1.322 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.769232e-02 | 1.322 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.997282e-02 | 1.301 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.202592e-02 | 1.284 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.223369e-02 | 1.282 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.223369e-02 | 1.282 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 6.207888e-02 | 1.207 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.742135e-02 | 1.241 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.742135e-02 | 1.241 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.742135e-02 | 1.241 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.742135e-02 | 1.241 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.228973e-02 | 1.206 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.716877e-02 | 1.243 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.716877e-02 | 1.243 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.341867e-02 | 1.198 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.341867e-02 | 1.198 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.198272e-02 | 1.208 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.198272e-02 | 1.208 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.198272e-02 | 1.208 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.756445e-02 | 1.240 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.953051e-02 | 1.225 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.285466e-02 | 1.277 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.228973e-02 | 1.206 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.198272e-02 | 1.208 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.228973e-02 | 1.206 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.589507e-02 | 1.253 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.082717e-02 | 1.216 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.719972e-02 | 1.243 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.963838e-02 | 1.224 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.123231e-02 | 1.213 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.388959e-02 | 1.268 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.435940e-02 | 1.191 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.659056e-02 | 1.177 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.659056e-02 | 1.177 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 6.659056e-02 | 1.177 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.688556e-02 | 1.175 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.754149e-02 | 1.170 | 0 | 0 |
| IRS activation | R-HSA-74713 | 7.500692e-02 | 1.125 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 7.500692e-02 | 1.125 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 7.500692e-02 | 1.125 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.323893e-02 | 1.135 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 8.494073e-02 | 1.071 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.037286e-02 | 1.153 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.003719e-02 | 1.155 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.003719e-02 | 1.155 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.484837e-02 | 1.071 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.619750e-02 | 1.118 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.839149e-02 | 1.106 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.436580e-02 | 1.074 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.637357e-02 | 1.117 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.436580e-02 | 1.074 | 1 | 1 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.896505e-02 | 1.103 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.494073e-02 | 1.071 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 7.500692e-02 | 1.125 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.494073e-02 | 1.071 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.986804e-02 | 1.098 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.286560e-02 | 1.137 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.848295e-02 | 1.105 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 8.494073e-02 | 1.071 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.702109e-02 | 1.113 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.370780e-02 | 1.132 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 8.494073e-02 | 1.071 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.117328e-02 | 1.148 | 1 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 7.848295e-02 | 1.105 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 8.542142e-02 | 1.068 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.951782e-02 | 1.048 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 9.032100e-02 | 1.044 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.147225e-02 | 1.039 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.206543e-02 | 1.036 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.343166e-02 | 1.030 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 9.404228e-02 | 1.027 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 9.404228e-02 | 1.027 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 9.404228e-02 | 1.027 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 9.404228e-02 | 1.027 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 9.404228e-02 | 1.027 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.545637e-02 | 1.020 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.638503e-02 | 1.016 | 1 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 9.737952e-02 | 1.012 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 9.737952e-02 | 1.012 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.840454e-02 | 1.007 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 9.840454e-02 | 1.007 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.840454e-02 | 1.007 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.840454e-02 | 1.007 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.840454e-02 | 1.007 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.840454e-02 | 1.007 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.010480e-01 | 0.995 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.013470e-01 | 0.994 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.203075e-01 | 0.920 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.203075e-01 | 0.920 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.203075e-01 | 0.920 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.203075e-01 | 0.920 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.203075e-01 | 0.920 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.203075e-01 | 0.920 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.142800e-01 | 0.942 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.142800e-01 | 0.942 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.354979e-01 | 0.868 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.354979e-01 | 0.868 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.354979e-01 | 0.868 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.105047e-01 | 0.957 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.242639e-01 | 0.906 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.242639e-01 | 0.906 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.242639e-01 | 0.906 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.386035e-01 | 0.858 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.290170e-01 | 0.889 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.262552e-01 | 0.899 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.130350e-01 | 0.947 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.286989e-01 | 0.890 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.090267e-01 | 0.962 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.386035e-01 | 0.858 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 1.386035e-01 | 0.858 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 1.386035e-01 | 0.858 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.116384e-01 | 0.952 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.085000e-01 | 0.965 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.290170e-01 | 0.889 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.105047e-01 | 0.957 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.142843e-01 | 0.942 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.142102e-01 | 0.942 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.172175e-01 | 0.931 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.185232e-01 | 0.926 | 1 | 1 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.203075e-01 | 0.920 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.356019e-01 | 0.868 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.242639e-01 | 0.906 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.290170e-01 | 0.889 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.197163e-01 | 0.922 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.327408e-01 | 0.877 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.290170e-01 | 0.889 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.290170e-01 | 0.889 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.172895e-01 | 0.931 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.211124e-01 | 0.917 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.122395e-01 | 0.950 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.085000e-01 | 0.965 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.101564e-01 | 0.958 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.354979e-01 | 0.868 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.386035e-01 | 0.858 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.085000e-01 | 0.965 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.282237e-01 | 0.892 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.328827e-01 | 0.877 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.076500e-01 | 0.968 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.211124e-01 | 0.917 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.231418e-01 | 0.910 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.369029e-01 | 0.864 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.196211e-01 | 0.922 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.403114e-01 | 0.853 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.403114e-01 | 0.853 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.430561e-01 | 0.844 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 1.430561e-01 | 0.844 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.438073e-01 | 0.842 | 1 | 1 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.438316e-01 | 0.842 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.452458e-01 | 0.838 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.453454e-01 | 0.838 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.464654e-01 | 0.834 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.480499e-01 | 0.830 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.480499e-01 | 0.830 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.480499e-01 | 0.830 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.749244e-01 | 0.757 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 1.749244e-01 | 0.757 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 1.749244e-01 | 0.757 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 1.749244e-01 | 0.757 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 1.749244e-01 | 0.757 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.261534e-01 | 0.646 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.261534e-01 | 0.646 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.261534e-01 | 0.646 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.261534e-01 | 0.646 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.261534e-01 | 0.646 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.261534e-01 | 0.646 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.261534e-01 | 0.646 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.261534e-01 | 0.646 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.261534e-01 | 0.646 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.261534e-01 | 0.646 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 2.742045e-01 | 0.562 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.742045e-01 | 0.562 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.742045e-01 | 0.562 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.574964e-01 | 0.803 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.574964e-01 | 0.803 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.800972e-01 | 0.744 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.800972e-01 | 0.744 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.800972e-01 | 0.744 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 3.192746e-01 | 0.496 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.192746e-01 | 0.496 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.192746e-01 | 0.496 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 3.192746e-01 | 0.496 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.031410e-01 | 0.692 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 2.031410e-01 | 0.692 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.264857e-01 | 0.645 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.264857e-01 | 0.645 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.264857e-01 | 0.645 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.264857e-01 | 0.645 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.264857e-01 | 0.645 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.264857e-01 | 0.645 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 3.615485e-01 | 0.442 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.615485e-01 | 0.442 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.615485e-01 | 0.442 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.615485e-01 | 0.442 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.688075e-01 | 0.773 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.500054e-01 | 0.602 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.500054e-01 | 0.602 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.735885e-01 | 0.563 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.735885e-01 | 0.563 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.735885e-01 | 0.563 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.735885e-01 | 0.563 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.735885e-01 | 0.563 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.735885e-01 | 0.563 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.735885e-01 | 0.563 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.735885e-01 | 0.563 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.735885e-01 | 0.563 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 4.011996e-01 | 0.397 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.011996e-01 | 0.397 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.011996e-01 | 0.397 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 4.011996e-01 | 0.397 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 4.011996e-01 | 0.397 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.011996e-01 | 0.397 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.763593e-01 | 0.754 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.763593e-01 | 0.754 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 2.971366e-01 | 0.527 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.971366e-01 | 0.527 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.338305e-01 | 0.631 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.019496e-01 | 0.695 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.019496e-01 | 0.695 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.507519e-01 | 0.601 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 3.205632e-01 | 0.494 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 3.205632e-01 | 0.494 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 4.383903e-01 | 0.358 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 4.383903e-01 | 0.358 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.383903e-01 | 0.358 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.865318e-01 | 0.729 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.437928e-01 | 0.464 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.437928e-01 | 0.464 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.850650e-01 | 0.545 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.850650e-01 | 0.545 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.908511e-01 | 0.719 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.199456e-01 | 0.658 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.023710e-01 | 0.519 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.667595e-01 | 0.436 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.667595e-01 | 0.436 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.005482e-01 | 0.698 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.894064e-01 | 0.410 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.669898e-01 | 0.574 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.116848e-01 | 0.385 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.716935e-01 | 0.430 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.335532e-01 | 0.363 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.335532e-01 | 0.363 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.888791e-01 | 0.410 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.888791e-01 | 0.410 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.054984e-01 | 0.515 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.054984e-01 | 0.515 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.059468e-01 | 0.392 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.549766e-01 | 0.342 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.534222e-01 | 0.452 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.388498e-01 | 0.470 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.613006e-01 | 0.442 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.910424e-01 | 0.408 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.160483e-01 | 0.381 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.176121e-01 | 0.379 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.532097e-01 | 0.344 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.400178e-01 | 0.357 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.400178e-01 | 0.357 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.285291e-01 | 0.368 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 4.465570e-01 | 0.350 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.865318e-01 | 0.729 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.239937e-01 | 0.650 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.888791e-01 | 0.410 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.171266e-01 | 0.663 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.613229e-01 | 0.792 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.019496e-01 | 0.695 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.865318e-01 | 0.729 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.372880e-01 | 0.625 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.865318e-01 | 0.729 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.408836e-01 | 0.356 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.124262e-01 | 0.505 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.800972e-01 | 0.744 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.914447e-01 | 0.718 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.431631e-01 | 0.614 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.431631e-01 | 0.614 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.358246e-01 | 0.627 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.800972e-01 | 0.744 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.031410e-01 | 0.692 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.534694e-01 | 0.814 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.264857e-01 | 0.645 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.758312e-01 | 0.755 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.785047e-01 | 0.422 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.171217e-01 | 0.499 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.192746e-01 | 0.496 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.192746e-01 | 0.496 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 3.615485e-01 | 0.442 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.735885e-01 | 0.563 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.437928e-01 | 0.464 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.228703e-01 | 0.374 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.154654e-01 | 0.667 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.154654e-01 | 0.667 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.376377e-01 | 0.624 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.284929e-01 | 0.368 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 2.735885e-01 | 0.563 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.640067e-01 | 0.785 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.951029e-01 | 0.403 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.089176e-01 | 0.388 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.800972e-01 | 0.744 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 2.264857e-01 | 0.645 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 3.615485e-01 | 0.442 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.615485e-01 | 0.442 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.615485e-01 | 0.442 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 2.500054e-01 | 0.602 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.335532e-01 | 0.363 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.985240e-01 | 0.400 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.845646e-01 | 0.734 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.971366e-01 | 0.527 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.072942e-01 | 0.683 | 1 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.228703e-01 | 0.374 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.519826e-01 | 0.818 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.011996e-01 | 0.397 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.116848e-01 | 0.385 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.116848e-01 | 0.385 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.082678e-01 | 0.681 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.971233e-01 | 0.705 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.410499e-01 | 0.356 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.385713e-01 | 0.622 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.910424e-01 | 0.408 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 3.513592e-01 | 0.454 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.653739e-01 | 0.782 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.850650e-01 | 0.545 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.888791e-01 | 0.410 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.532097e-01 | 0.344 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.385713e-01 | 0.622 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.602793e-01 | 0.585 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.500054e-01 | 0.602 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.698593e-01 | 0.432 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.602793e-01 | 0.585 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.894103e-01 | 0.723 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 3.613006e-01 | 0.442 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.176121e-01 | 0.379 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.538176e-01 | 0.343 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.575168e-01 | 0.447 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 1.749244e-01 | 0.757 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.749244e-01 | 0.757 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 2.261534e-01 | 0.646 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 2.261534e-01 | 0.646 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.261534e-01 | 0.646 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.742045e-01 | 0.562 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.742045e-01 | 0.562 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.192746e-01 | 0.496 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.534694e-01 | 0.814 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 2.264857e-01 | 0.645 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.615485e-01 | 0.442 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.500054e-01 | 0.602 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.500054e-01 | 0.602 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.500054e-01 | 0.602 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.500054e-01 | 0.602 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.500054e-01 | 0.602 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.971366e-01 | 0.527 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.890153e-01 | 0.724 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.437928e-01 | 0.464 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.023710e-01 | 0.519 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.894064e-01 | 0.410 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.544182e-01 | 0.450 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.562857e-01 | 0.591 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.335532e-01 | 0.363 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.659475e-01 | 0.575 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.757073e-01 | 0.560 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.549766e-01 | 0.342 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 4.549766e-01 | 0.342 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.689677e-01 | 0.772 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.560085e-01 | 0.807 | 1 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.452095e-01 | 0.610 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.753061e-01 | 0.756 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.089835e-01 | 0.388 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.205632e-01 | 0.494 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.803689e-01 | 0.552 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.974610e-01 | 0.705 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.436201e-01 | 0.464 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.842117e-01 | 0.415 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.717288e-01 | 0.566 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.205632e-01 | 0.494 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 3.716935e-01 | 0.430 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.335532e-01 | 0.363 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.834043e-01 | 0.548 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.620721e-01 | 0.582 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.606017e-01 | 0.584 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.151366e-01 | 0.667 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.437928e-01 | 0.464 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.673479e-01 | 0.776 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.606017e-01 | 0.584 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.673479e-01 | 0.776 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.673479e-01 | 0.776 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.227620e-01 | 0.652 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 3.192746e-01 | 0.496 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 3.615485e-01 | 0.442 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.735885e-01 | 0.563 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.735885e-01 | 0.563 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.735885e-01 | 0.563 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.011996e-01 | 0.397 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.799707e-01 | 0.420 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.697855e-01 | 0.770 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.528654e-01 | 0.597 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.288321e-01 | 0.368 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.517907e-01 | 0.454 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.640067e-01 | 0.785 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 3.205632e-01 | 0.494 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.059468e-01 | 0.392 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.894064e-01 | 0.410 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.311882e-01 | 0.365 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.842524e-01 | 0.546 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.084805e-01 | 0.511 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 3.192746e-01 | 0.496 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.031410e-01 | 0.692 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.500054e-01 | 0.602 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.845646e-01 | 0.734 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.011996e-01 | 0.397 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.437928e-01 | 0.464 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.894064e-01 | 0.410 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 4.116848e-01 | 0.385 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.151366e-01 | 0.667 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.532097e-01 | 0.344 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.727852e-01 | 0.564 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.974610e-01 | 0.705 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.994564e-01 | 0.700 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.835044e-01 | 0.416 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.872747e-01 | 0.412 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.248981e-01 | 0.488 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.036031e-01 | 0.518 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 2.264857e-01 | 0.645 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.890153e-01 | 0.724 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.314704e-01 | 0.636 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.314913e-01 | 0.635 | 1 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.549766e-01 | 0.342 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.549766e-01 | 0.342 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.410499e-01 | 0.356 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.838315e-01 | 0.416 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.256196e-01 | 0.371 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.549766e-01 | 0.342 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.667542e-01 | 0.778 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.938474e-01 | 0.532 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.299616e-01 | 0.482 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 4.532097e-01 | 0.344 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.549766e-01 | 0.342 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.800972e-01 | 0.744 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.800972e-01 | 0.744 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.205632e-01 | 0.494 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 4.383903e-01 | 0.358 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.758312e-01 | 0.755 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 3.667595e-01 | 0.436 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 3.667595e-01 | 0.436 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.306563e-01 | 0.637 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.981640e-01 | 0.526 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.338305e-01 | 0.631 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.370838e-01 | 0.472 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 2.945090e-01 | 0.531 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 2.971366e-01 | 0.527 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.116848e-01 | 0.385 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.800972e-01 | 0.744 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.370838e-01 | 0.472 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.335532e-01 | 0.363 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.374037e-01 | 0.359 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.116848e-01 | 0.385 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.562857e-01 | 0.591 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.269591e-01 | 0.370 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.615485e-01 | 0.442 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.688075e-01 | 0.773 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.011996e-01 | 0.397 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.507519e-01 | 0.601 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 4.383903e-01 | 0.358 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.437928e-01 | 0.464 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.116848e-01 | 0.385 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.838315e-01 | 0.416 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.269591e-01 | 0.370 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.331740e-01 | 0.477 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.562431e-01 | 0.448 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.054984e-01 | 0.515 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.054984e-01 | 0.515 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.072942e-01 | 0.683 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 4.011996e-01 | 0.397 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.667595e-01 | 0.436 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.544182e-01 | 0.450 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.264857e-01 | 0.645 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.127786e-01 | 0.384 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.507519e-01 | 0.601 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.437928e-01 | 0.464 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 4.549766e-01 | 0.342 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.431631e-01 | 0.614 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.431631e-01 | 0.614 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 2.735885e-01 | 0.563 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.981640e-01 | 0.526 | 1 | 1 |
| Glycolysis | R-HSA-70171 | 1.805352e-01 | 0.743 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.667595e-01 | 0.436 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.335532e-01 | 0.363 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.894064e-01 | 0.410 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.031410e-01 | 0.692 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.985240e-01 | 0.400 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.197230e-01 | 0.495 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.331740e-01 | 0.477 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.019496e-01 | 0.695 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.550362e-01 | 0.342 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.561909e-01 | 0.341 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.561909e-01 | 0.341 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.561909e-01 | 0.341 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.561909e-01 | 0.341 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.561909e-01 | 0.341 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.627008e-01 | 0.335 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.659247e-01 | 0.332 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.725459e-01 | 0.326 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.725459e-01 | 0.326 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 4.732733e-01 | 0.325 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.732733e-01 | 0.325 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 4.732733e-01 | 0.325 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.732733e-01 | 0.325 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 4.732733e-01 | 0.325 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 4.732733e-01 | 0.325 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.732733e-01 | 0.325 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 4.732733e-01 | 0.325 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.732733e-01 | 0.325 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.732733e-01 | 0.325 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.732733e-01 | 0.325 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.732733e-01 | 0.325 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.732733e-01 | 0.325 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.732892e-01 | 0.325 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.759259e-01 | 0.322 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.759259e-01 | 0.322 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.759259e-01 | 0.322 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 4.759259e-01 | 0.322 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.826409e-01 | 0.316 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.826409e-01 | 0.316 | 1 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.839835e-01 | 0.315 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 4.886727e-01 | 0.311 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.886727e-01 | 0.311 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.886727e-01 | 0.311 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.896187e-01 | 0.310 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.897019e-01 | 0.310 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.951572e-01 | 0.305 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.962343e-01 | 0.304 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.963774e-01 | 0.304 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.963774e-01 | 0.304 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.963774e-01 | 0.304 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.963774e-01 | 0.304 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.963774e-01 | 0.304 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.016732e-01 | 0.300 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.024985e-01 | 0.299 | 1 | 0 |
| Influenza Infection | R-HSA-168255 | 5.028456e-01 | 0.299 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.045551e-01 | 0.297 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 5.059916e-01 | 0.296 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.059916e-01 | 0.296 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.059916e-01 | 0.296 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 5.059916e-01 | 0.296 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 5.059916e-01 | 0.296 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.059916e-01 | 0.296 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.059916e-01 | 0.296 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.059916e-01 | 0.296 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 5.059916e-01 | 0.296 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 5.059916e-01 | 0.296 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 5.059916e-01 | 0.296 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.059916e-01 | 0.296 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.059916e-01 | 0.296 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.096733e-01 | 0.293 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 5.096733e-01 | 0.293 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.126983e-01 | 0.290 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.163121e-01 | 0.287 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.163121e-01 | 0.287 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.167109e-01 | 0.287 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.201784e-01 | 0.284 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.201784e-01 | 0.284 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.201784e-01 | 0.284 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.201784e-01 | 0.284 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.201784e-01 | 0.284 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.201784e-01 | 0.284 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.252767e-01 | 0.280 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.252767e-01 | 0.280 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.261656e-01 | 0.279 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.262355e-01 | 0.279 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.355298e-01 | 0.271 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.355298e-01 | 0.271 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.357154e-01 | 0.271 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.357154e-01 | 0.271 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.357154e-01 | 0.271 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.357154e-01 | 0.271 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.357154e-01 | 0.271 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.357154e-01 | 0.271 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.358157e-01 | 0.271 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.360471e-01 | 0.271 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.360471e-01 | 0.271 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.360471e-01 | 0.271 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.360471e-01 | 0.271 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 5.366794e-01 | 0.270 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.366794e-01 | 0.270 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.366794e-01 | 0.270 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.366794e-01 | 0.270 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.366794e-01 | 0.270 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.366794e-01 | 0.270 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 5.366794e-01 | 0.270 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 5.366794e-01 | 0.270 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.366794e-01 | 0.270 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.366794e-01 | 0.270 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.366794e-01 | 0.270 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 5.366794e-01 | 0.270 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.379007e-01 | 0.269 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.389865e-01 | 0.268 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.400231e-01 | 0.268 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.412457e-01 | 0.267 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.412457e-01 | 0.267 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.412457e-01 | 0.267 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.450378e-01 | 0.264 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.483789e-01 | 0.261 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.489637e-01 | 0.260 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.489637e-01 | 0.260 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.489637e-01 | 0.260 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.511659e-01 | 0.259 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.527684e-01 | 0.257 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.545763e-01 | 0.256 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.545763e-01 | 0.256 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.545763e-01 | 0.256 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.545763e-01 | 0.256 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.568742e-01 | 0.254 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.592326e-01 | 0.252 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.597254e-01 | 0.252 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.616894e-01 | 0.251 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.622523e-01 | 0.250 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.653735e-01 | 0.248 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.654626e-01 | 0.248 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.654626e-01 | 0.248 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 5.654626e-01 | 0.248 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.654626e-01 | 0.248 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.654626e-01 | 0.248 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.654626e-01 | 0.248 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.654626e-01 | 0.248 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.654626e-01 | 0.248 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.654626e-01 | 0.248 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 5.654626e-01 | 0.248 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.654626e-01 | 0.248 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.654626e-01 | 0.248 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.654626e-01 | 0.248 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.654626e-01 | 0.248 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.709275e-01 | 0.243 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.728874e-01 | 0.242 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.798476e-01 | 0.237 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.798476e-01 | 0.237 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.798476e-01 | 0.237 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.798476e-01 | 0.237 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.798476e-01 | 0.237 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.798476e-01 | 0.237 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.798476e-01 | 0.237 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.804817e-01 | 0.236 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.819799e-01 | 0.235 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.820952e-01 | 0.235 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.865397e-01 | 0.232 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.872996e-01 | 0.231 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.906442e-01 | 0.229 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.906442e-01 | 0.229 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.906442e-01 | 0.229 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.906442e-01 | 0.229 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.923397e-01 | 0.227 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.924593e-01 | 0.227 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.924593e-01 | 0.227 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.924593e-01 | 0.227 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 5.924593e-01 | 0.227 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.924593e-01 | 0.227 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.928776e-01 | 0.227 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.940134e-01 | 0.226 | 1 | 1 |
| FLT3 Signaling | R-HSA-9607240 | 5.940134e-01 | 0.226 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 5.940134e-01 | 0.226 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.986522e-01 | 0.223 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.078448e-01 | 0.216 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.078448e-01 | 0.216 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.078448e-01 | 0.216 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.078651e-01 | 0.216 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.078651e-01 | 0.216 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.141915e-01 | 0.212 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.177802e-01 | 0.209 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.177802e-01 | 0.209 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.177802e-01 | 0.209 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.177802e-01 | 0.209 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.177802e-01 | 0.209 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 6.177802e-01 | 0.209 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.213981e-01 | 0.207 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.222267e-01 | 0.206 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.244898e-01 | 0.204 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.244898e-01 | 0.204 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.244898e-01 | 0.204 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.244898e-01 | 0.204 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.244898e-01 | 0.204 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.244898e-01 | 0.204 | 1 | 1 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.346090e-01 | 0.197 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.346570e-01 | 0.197 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.348379e-01 | 0.197 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.348379e-01 | 0.197 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.386659e-01 | 0.195 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 6.405819e-01 | 0.193 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.405819e-01 | 0.193 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.405819e-01 | 0.193 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.415294e-01 | 0.193 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.415294e-01 | 0.193 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.415294e-01 | 0.193 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 6.415294e-01 | 0.193 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 6.415294e-01 | 0.193 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.415294e-01 | 0.193 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.415294e-01 | 0.193 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.415294e-01 | 0.193 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.415294e-01 | 0.193 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.419262e-01 | 0.193 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.449078e-01 | 0.191 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.490841e-01 | 0.188 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.547922e-01 | 0.184 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.559057e-01 | 0.183 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.561255e-01 | 0.183 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.561255e-01 | 0.183 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.561255e-01 | 0.183 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.561255e-01 | 0.183 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.561622e-01 | 0.183 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.600551e-01 | 0.180 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.600551e-01 | 0.180 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 6.638043e-01 | 0.178 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.638043e-01 | 0.178 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 6.638043e-01 | 0.178 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.638043e-01 | 0.178 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 6.638043e-01 | 0.178 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.638043e-01 | 0.178 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 6.638043e-01 | 0.178 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 6.638043e-01 | 0.178 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.638043e-01 | 0.178 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.638043e-01 | 0.178 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.645037e-01 | 0.178 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.645037e-01 | 0.178 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.648631e-01 | 0.177 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.650244e-01 | 0.177 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.711266e-01 | 0.173 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.711266e-01 | 0.173 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.711266e-01 | 0.173 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.752115e-01 | 0.171 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.752115e-01 | 0.171 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.752115e-01 | 0.171 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.772060e-01 | 0.169 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.836526e-01 | 0.165 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.841944e-01 | 0.165 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.841944e-01 | 0.165 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.846963e-01 | 0.165 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.846963e-01 | 0.165 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.846963e-01 | 0.165 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 6.846963e-01 | 0.165 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.846963e-01 | 0.165 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.846963e-01 | 0.165 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 6.855926e-01 | 0.164 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.875058e-01 | 0.163 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.887968e-01 | 0.162 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.899907e-01 | 0.161 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.925548e-01 | 0.160 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.957747e-01 | 0.158 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.968896e-01 | 0.157 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.983048e-01 | 0.156 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.995321e-01 | 0.155 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.995321e-01 | 0.155 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.995321e-01 | 0.155 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.015400e-01 | 0.154 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.042912e-01 | 0.152 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.042912e-01 | 0.152 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.042912e-01 | 0.152 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.042912e-01 | 0.152 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.042912e-01 | 0.152 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.042912e-01 | 0.152 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.042912e-01 | 0.152 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.042912e-01 | 0.152 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.042912e-01 | 0.152 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.042912e-01 | 0.152 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.042912e-01 | 0.152 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.103415e-01 | 0.149 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.104355e-01 | 0.148 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.118271e-01 | 0.148 | 1 | 1 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.129545e-01 | 0.147 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.129545e-01 | 0.147 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.129545e-01 | 0.147 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.179647e-01 | 0.144 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.189589e-01 | 0.143 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.223413e-01 | 0.141 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.226695e-01 | 0.141 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.226695e-01 | 0.141 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.226695e-01 | 0.141 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.226695e-01 | 0.141 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.226695e-01 | 0.141 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 7.226695e-01 | 0.141 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.226695e-01 | 0.141 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.258704e-01 | 0.139 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.273922e-01 | 0.138 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.285792e-01 | 0.138 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.356416e-01 | 0.133 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.376019e-01 | 0.132 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.382908e-01 | 0.132 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.382908e-01 | 0.132 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.382908e-01 | 0.132 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.382908e-01 | 0.132 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.382908e-01 | 0.132 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.382908e-01 | 0.132 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.388776e-01 | 0.131 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.388776e-01 | 0.131 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.399066e-01 | 0.131 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.399066e-01 | 0.131 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.399066e-01 | 0.131 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.399066e-01 | 0.131 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 7.399066e-01 | 0.131 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.399066e-01 | 0.131 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.399066e-01 | 0.131 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.437076e-01 | 0.129 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.443879e-01 | 0.128 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.443879e-01 | 0.128 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.443879e-01 | 0.128 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.443879e-01 | 0.128 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.488635e-01 | 0.126 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.502274e-01 | 0.125 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.502274e-01 | 0.125 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.502274e-01 | 0.125 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.502274e-01 | 0.125 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.502274e-01 | 0.125 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.560733e-01 | 0.121 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.560733e-01 | 0.121 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.560733e-01 | 0.121 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 7.560733e-01 | 0.121 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.560733e-01 | 0.121 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.560733e-01 | 0.121 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.560733e-01 | 0.121 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.592919e-01 | 0.120 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.607771e-01 | 0.119 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.616923e-01 | 0.118 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 7.616923e-01 | 0.118 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.663178e-01 | 0.116 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.668122e-01 | 0.115 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.679153e-01 | 0.115 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.679153e-01 | 0.115 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.688602e-01 | 0.114 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.697105e-01 | 0.114 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.712361e-01 | 0.113 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.712361e-01 | 0.113 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.712361e-01 | 0.113 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.712361e-01 | 0.113 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 7.712361e-01 | 0.113 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.712361e-01 | 0.113 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.712361e-01 | 0.113 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.712361e-01 | 0.113 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.712361e-01 | 0.113 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 7.726980e-01 | 0.112 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.769904e-01 | 0.110 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.769904e-01 | 0.110 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.777013e-01 | 0.109 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.813154e-01 | 0.107 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.832573e-01 | 0.106 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.838296e-01 | 0.106 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.854572e-01 | 0.105 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 7.854572e-01 | 0.105 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 7.854572e-01 | 0.105 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.854572e-01 | 0.105 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.854572e-01 | 0.105 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 7.854572e-01 | 0.105 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 7.854572e-01 | 0.105 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.854714e-01 | 0.105 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.933594e-01 | 0.101 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.933832e-01 | 0.101 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.942648e-01 | 0.100 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.942648e-01 | 0.100 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.987950e-01 | 0.098 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.987950e-01 | 0.098 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.987950e-01 | 0.098 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.987950e-01 | 0.098 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.987950e-01 | 0.098 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.987950e-01 | 0.098 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.987950e-01 | 0.098 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.987950e-01 | 0.098 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.003604e-01 | 0.097 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.003607e-01 | 0.097 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.030886e-01 | 0.095 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.030886e-01 | 0.095 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.030886e-01 | 0.095 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.030886e-01 | 0.095 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.030886e-01 | 0.095 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.034219e-01 | 0.095 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.049093e-01 | 0.094 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.113044e-01 | 0.091 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.113044e-01 | 0.091 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.113044e-01 | 0.091 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.113044e-01 | 0.091 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.113044e-01 | 0.091 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.113044e-01 | 0.091 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.113044e-01 | 0.091 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 8.113044e-01 | 0.091 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 8.113044e-01 | 0.091 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.113044e-01 | 0.091 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.113044e-01 | 0.091 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.123868e-01 | 0.090 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.123868e-01 | 0.090 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.123868e-01 | 0.090 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.145155e-01 | 0.089 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.198198e-01 | 0.086 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.212908e-01 | 0.086 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.212908e-01 | 0.086 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.212908e-01 | 0.086 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.212908e-01 | 0.086 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.212908e-01 | 0.086 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.227127e-01 | 0.085 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.230367e-01 | 0.085 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.230367e-01 | 0.085 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.230367e-01 | 0.085 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.230367e-01 | 0.085 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.230367e-01 | 0.085 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.230367e-01 | 0.085 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.230367e-01 | 0.085 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.230367e-01 | 0.085 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.230367e-01 | 0.085 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.250427e-01 | 0.084 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.254681e-01 | 0.083 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.285191e-01 | 0.082 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.298136e-01 | 0.081 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.298136e-01 | 0.081 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.326067e-01 | 0.080 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.340403e-01 | 0.079 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.340403e-01 | 0.079 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.340403e-01 | 0.079 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.340403e-01 | 0.079 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.340403e-01 | 0.079 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.340403e-01 | 0.079 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.340403e-01 | 0.079 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.340403e-01 | 0.079 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.379276e-01 | 0.077 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.379683e-01 | 0.077 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.380650e-01 | 0.077 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.394929e-01 | 0.076 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.424771e-01 | 0.074 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.443337e-01 | 0.073 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.443602e-01 | 0.073 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.443602e-01 | 0.073 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.443602e-01 | 0.073 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.443602e-01 | 0.073 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.443602e-01 | 0.073 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.443602e-01 | 0.073 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.457676e-01 | 0.073 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.488885e-01 | 0.071 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.532242e-01 | 0.069 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.540391e-01 | 0.069 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.540391e-01 | 0.069 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.540391e-01 | 0.069 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.540391e-01 | 0.069 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.591056e-01 | 0.066 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.603505e-01 | 0.065 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.603505e-01 | 0.065 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.603505e-01 | 0.065 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.603505e-01 | 0.065 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.626633e-01 | 0.064 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.631165e-01 | 0.064 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.631165e-01 | 0.064 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.631165e-01 | 0.064 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 8.631165e-01 | 0.064 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.631165e-01 | 0.064 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.631165e-01 | 0.064 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.631165e-01 | 0.064 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.631165e-01 | 0.064 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.631165e-01 | 0.064 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.631165e-01 | 0.064 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.631165e-01 | 0.064 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.669592e-01 | 0.062 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.669592e-01 | 0.062 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.671588e-01 | 0.062 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.699707e-01 | 0.060 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.713581e-01 | 0.060 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.716300e-01 | 0.060 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.716300e-01 | 0.060 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.716300e-01 | 0.060 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.716300e-01 | 0.060 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.716300e-01 | 0.060 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.728582e-01 | 0.059 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.728582e-01 | 0.059 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.729048e-01 | 0.059 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.733426e-01 | 0.059 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.755805e-01 | 0.058 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.758614e-01 | 0.058 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.758614e-01 | 0.058 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.777738e-01 | 0.057 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.796144e-01 | 0.056 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 8.796144e-01 | 0.056 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.796144e-01 | 0.056 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.796144e-01 | 0.056 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.796144e-01 | 0.056 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.796144e-01 | 0.056 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.811572e-01 | 0.055 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.821410e-01 | 0.054 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.871027e-01 | 0.052 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.871027e-01 | 0.052 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.871027e-01 | 0.052 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.914224e-01 | 0.050 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.914224e-01 | 0.050 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.914224e-01 | 0.050 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.914469e-01 | 0.050 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 8.941256e-01 | 0.049 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.956658e-01 | 0.048 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 8.958569e-01 | 0.048 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.968392e-01 | 0.047 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.968392e-01 | 0.047 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.968392e-01 | 0.047 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.997627e-01 | 0.046 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.007120e-01 | 0.045 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.007120e-01 | 0.045 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.019811e-01 | 0.045 | 1 | 1 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.025123e-01 | 0.045 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.068830e-01 | 0.042 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.068830e-01 | 0.042 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.068891e-01 | 0.042 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.068891e-01 | 0.042 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.068891e-01 | 0.042 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.085917e-01 | 0.042 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.115548e-01 | 0.040 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.117455e-01 | 0.040 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.122637e-01 | 0.040 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.126822e-01 | 0.040 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.129088e-01 | 0.040 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.160062e-01 | 0.038 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.181152e-01 | 0.037 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.181152e-01 | 0.037 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.181152e-01 | 0.037 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.209472e-01 | 0.036 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.232104e-01 | 0.035 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 9.232104e-01 | 0.035 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.232104e-01 | 0.035 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 9.246533e-01 | 0.034 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.277287e-01 | 0.033 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.279889e-01 | 0.032 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.279889e-01 | 0.032 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.279889e-01 | 0.032 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.279889e-01 | 0.032 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.279889e-01 | 0.032 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.279889e-01 | 0.032 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.279889e-01 | 0.032 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.317890e-01 | 0.031 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.324704e-01 | 0.030 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.324704e-01 | 0.030 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.346553e-01 | 0.029 | 1 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.362557e-01 | 0.029 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.362557e-01 | 0.029 | 1 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.366731e-01 | 0.028 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.366731e-01 | 0.028 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.366731e-01 | 0.028 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.366731e-01 | 0.028 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.379185e-01 | 0.028 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.385858e-01 | 0.028 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.385858e-01 | 0.028 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.396188e-01 | 0.027 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.406146e-01 | 0.027 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.406146e-01 | 0.027 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.406146e-01 | 0.027 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.406146e-01 | 0.027 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.406146e-01 | 0.027 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.443110e-01 | 0.025 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.443110e-01 | 0.025 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.447364e-01 | 0.025 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.475874e-01 | 0.023 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.477774e-01 | 0.023 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.477774e-01 | 0.023 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.477774e-01 | 0.023 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.477774e-01 | 0.023 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.477774e-01 | 0.023 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.510284e-01 | 0.022 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.522281e-01 | 0.021 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.528741e-01 | 0.021 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.528741e-01 | 0.021 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.540771e-01 | 0.020 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.540771e-01 | 0.020 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.540771e-01 | 0.020 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.569362e-01 | 0.019 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.569362e-01 | 0.019 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.569362e-01 | 0.019 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.596174e-01 | 0.018 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 9.602595e-01 | 0.018 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.602595e-01 | 0.018 | 1 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.609336e-01 | 0.017 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.619582e-01 | 0.017 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.621319e-01 | 0.017 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.621319e-01 | 0.017 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.644899e-01 | 0.016 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.644899e-01 | 0.016 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.644899e-01 | 0.016 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.644899e-01 | 0.016 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.644899e-01 | 0.016 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.651720e-01 | 0.015 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.666798e-01 | 0.015 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.666798e-01 | 0.015 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.667013e-01 | 0.015 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.667013e-01 | 0.015 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.667013e-01 | 0.015 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.667013e-01 | 0.015 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.667013e-01 | 0.015 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.667013e-01 | 0.015 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.667013e-01 | 0.015 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.674281e-01 | 0.014 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.687750e-01 | 0.014 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.687750e-01 | 0.014 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.687750e-01 | 0.014 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.689440e-01 | 0.014 | 1 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.700260e-01 | 0.013 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.707198e-01 | 0.013 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.709672e-01 | 0.013 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.718927e-01 | 0.012 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.725435e-01 | 0.012 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.742537e-01 | 0.011 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.742537e-01 | 0.011 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.742537e-01 | 0.011 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.742537e-01 | 0.011 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.753446e-01 | 0.011 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.766565e-01 | 0.010 | 1 | 1 |
| Complex IV assembly | R-HSA-9864848 | 9.773615e-01 | 0.010 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.773615e-01 | 0.010 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.773615e-01 | 0.010 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 9.779008e-01 | 0.010 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.800945e-01 | 0.009 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.800945e-01 | 0.009 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.801995e-01 | 0.009 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.815423e-01 | 0.008 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.827941e-01 | 0.008 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.827941e-01 | 0.008 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.827941e-01 | 0.008 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.835884e-01 | 0.007 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.841823e-01 | 0.007 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.841823e-01 | 0.007 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.846112e-01 | 0.007 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.849776e-01 | 0.007 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.849776e-01 | 0.007 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.855702e-01 | 0.006 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.864696e-01 | 0.006 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.864696e-01 | 0.006 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.873129e-01 | 0.006 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.873129e-01 | 0.006 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.895408e-01 | 0.005 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.895408e-01 | 0.005 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.907507e-01 | 0.004 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.909094e-01 | 0.004 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.912949e-01 | 0.004 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.914061e-01 | 0.004 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.914061e-01 | 0.004 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.918763e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.919153e-01 | 0.004 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.919153e-01 | 0.004 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.924127e-01 | 0.003 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.924195e-01 | 0.003 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.927424e-01 | 0.003 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.927424e-01 | 0.003 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.927712e-01 | 0.003 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.933355e-01 | 0.003 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.933355e-01 | 0.003 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.935525e-01 | 0.003 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.945065e-01 | 0.002 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.948190e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.948492e-01 | 0.002 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.958859e-01 | 0.002 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 9.959019e-01 | 0.002 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.960193e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.960193e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.960193e-01 | 0.002 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.961950e-01 | 0.002 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.967190e-01 | 0.001 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.969095e-01 | 0.001 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.969095e-01 | 0.001 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.971663e-01 | 0.001 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.971807e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.973987e-01 | 0.001 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.974828e-01 | 0.001 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.975899e-01 | 0.001 | 1 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.976817e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.976817e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.977713e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.979342e-01 | 0.001 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.980409e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.980630e-01 | 0.001 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.982672e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.983609e-01 | 0.001 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.983855e-01 | 0.001 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.984863e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.985809e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.987960e-01 | 0.001 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.988323e-01 | 0.001 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.988941e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.989036e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.989721e-01 | 0.000 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.989721e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.990749e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.991530e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.991578e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.992059e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.992556e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.992595e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.993457e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.993519e-01 | 0.000 | 1 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.996096e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.996341e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.997420e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.998519e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.998519e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.998856e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.998891e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999113e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999159e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999198e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999224e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999284e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999362e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999497e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999758e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999801e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999806e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999825e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999920e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999946e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999950e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999958e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999958e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999970e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999970e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999982e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999982e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999989e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999989e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |